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Abstract
Despite many national interventions, cervical cancer (CC) rates persist, and in Kentucky
(KY), CC incidence rates are on the rise. Additionally, women with disabilities face more
barriers to secondary prevention and healthcare access, have more known risks, and
experience more health disparities than women without disabilities. Given that 1 in 4
persons live with a disability, the purpose of this observational, cross-sectional,
quantitative study was to explore the relationship between CC and women with
disabilities as evidenced by reproductive cancer discharges from inpatient hospital (IHD)
and outpatient services databases (OSD) so as to compare population-specific differences
from social determinants of health framework. Data from the Kentucky Cabinet for
Health and Family Services for 2015 to 2018 were analyzed using MLR. In total, the
sample included 584 women with disabilities and 32,773 women without disabilities
living in KY. Results of the IHD data analysis found that county of residence (p =.014)
and insurance payer (p = .000) were statistically significant and that women on Medicaid
were 9.6 times as likely to be diagnosed with CC. Results of the OSD data analysis found
that county (p = .000) and age group (p = .000) were statistically significant and that
women aged 40-44 were 9.5 and 2.9 times as likely to have breast cancer and CC
respectively. This study’s findings call for greater attention to the determinants that affect
health factors among women in KY, to the visibility of people with disabilities in the
data, and to tailored interventions that ensure increased access to value-based health
services for women in KY thereby decreasing health disparities, especially for women
with disabilities.
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Chapter 1: Introduction to the Study
Chronic diseases, such as cancer, have become a significant challenge among
people with disabilities (PWD), specifically those living with intellectual and
developmental disabilities (IDD). This can be attributed to the fact that this population is
living longer than before given advances in technology and person-centered improved
supports (Parish, Son, Powell & Igdalsky, 2018). Further research shows women with
IDD are diagnosed with cancer at later stages and present with tumors of advanced
cancers at younger ages than the general population (Satgé et al., 2014). Breast cancer
has been noted at the same incidence rate among women with IDD than those without
IDD (Partja, Eero, & Livanainen, 2001; Sullivan et al., 2003). However, additional breast
cancer risk factors have been noted among women with IDD than those without (Taggart,
Truesdale-Kennedy, & McIlfatrick, 2011). Women with IDD are at greater risk of
developing uterine and ovarian cancers than cervical cancer (CC), although the disease
etiology of cancer could lead to different incidence rates (Parish et al., 2018). According
to Reichard, Haile, and Morris (2019), Medicare fee-for-service recipients with chronic
physical conditions have higher rates of emergency department admissions as well as
higher rates of 30-day readmissions than non-Medicare recipients. African-American
women with IDD received breast cancer screenings at lower rates than White women
with IDD (Parish, Swaine, Son, & Luken, 2013b). Further, women with IDD are half as
likely to be screened for CC and one and a half times as likely to be screened for breast
cancer as women without IDD (Cobigo et al., 2013).
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In this quantitative, epidemiological study I used secondary data to investigate the
disparities of CC in a manner that “include population-specific differences in health
indicators between women with disabilities and those without disabilities” (Drum, Krahn,
& Bersani, 2009, p. 138). The health of some populations is negatively impacted due to
disparities that occur when different populations have lived experiences of discrimination
and bias due to social status and underlying differences (Drum et al., 2009). With this
study, I aimed to contribute to the advancement of health outcomes among women with
disabilities in a way that advocates for inclusive public health services that ameliorates
health disparities within this population.
The approach for this study included the use of secondary data, and the
anticipated concerns of the present era where people with IDD are invisible in data
(Havercamp & Krahn, 2019) was realized. The proposed plan was to examine the
relationship of CC and other variables that included women with IDD; however, these
women were invisible in data, and it was therefore not possible to examine the
differences with this very important demographic of the population. The International
Classification of Disease, 10th Revision, Clinical Modifications (ICD-10-CM) codes that
would have identified women with IDD were either not used by hospitals and outpatient
services whose data contributed to this study, or it was not common practice to include
these codes when women with IDD were being treated for cancer, a non-IDD condition.
In view of the invisibility in data for women with IDD, it was necessary to
include that for the purpose of this study, women with disabilities will refer to all types of
disabilities (which include IDD). When IDD is used in this study, the term will refer to
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that specific demographic within the larger disability demographic. This study
contributes in a small way to the use of available administrative data and also affirms the
growing need for a robust, collaborated health surveillance system toward improved
health services for this demographic in the general population
This chapter introduces the study problem followed by the study’s purpose,
research questions, and the theoretical framework used. The significance of the study will
also be presented along with the implications for social change.
Background
From a Centers for Disease Control and Prevention’s (CDC) 2016 report, among
all PWD, about 32% live in rural areas while about 24% live in large, central
metropolitan areas (CDC, 2020c). Overall, over 61 million people (1 in 4) live with a
disability. Six domains are used to determine a person’s disability status based on the
functional level of known deficits, including hearing, vision, cognition, mobility, selfcare, and independent living deficits (CDC, 2020d). Given the above domains to help
determine a person’s disability status, there is a growing body of concern about the
inconsistency of the prevalence of persons with IDD. A recent systemic review indicated
that, among adults, the prevalence was estimated at 41.0 per 1,000 people for
developmental disabilities (DD) while that of ID and/or DD was 7.9 per 1,000 for adults,
a rate much lower than that of children, which was noted at 38.2 per 1,000 from birth to
age 5. In addition, among working-age adults, about 137 per 1,000 receive Social
Security income or disability benefits and noted as the prevalence of ID from
administrative data (Anderson, Larson, MapelLentz, & Hall-Lande, 2019). Although the
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prevalence rates of women with IDD are not known, rates of men with IDD are about 36
per 1,000, and the CDC estimates more women than men live with IDD (CDC, 2020c).
PWD experience health disparities in many forms, which excludes this population
from secondary prevention measures. Screening for CC continues to be a key prevention
measure for CC control and treatment. Ouellette-Kuntz, Cobigo, Balogh, Wilton, and
Lunksy (2015) noted that, within a 2-year period, 22% of adults with disabilities had a
physician health examination compared to 26.4 % for adults without a disability. It is also
well documented that adults with disabilities do not undergo screening at the
recommended age nor the gender-specific screening for such cancers as cervical, breast,
or colorectal (Ouellette-Kuntz et al., 2015).
The U.S. Preventative Services Task Force (USPSTF, 2018) recommends CC
screening with cervical cytology only every 3 years for women aged 21-29. For women
aged 30-65, the recommendation is every 3 years for cervical cytology only, or every 5
years for a combined, high-risk HPV test with cervical cytology (USPSTF, 2018). For
women aged 50-74, the USPSTF recommends biennial mammography screening. For
women with a known high risk or who want to start early, the USPSTF recommends
biennial screening between the ages of 40-49 (USPSTF, 2018).
Despite these recommendations, Plourde, Brown, Vigod, and Cobigo (2018)
found that women with IDD were less likely to be screened for CC using a pap smear
even with high to moderate levels of continuity of care as compared to low continuity of
care. In addition, women with IDD have been noted to lag women with less severe
disabilities as well as behind women without disabilities with regard to pap tests and
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mammograms. When controlling for geographic, demographic, and socioeconomic
factors, women with more severe disabilities experience even higher disparities (HornerJohnson, Dobbertin, Andresen, & Iezzoni, 2014). Furthermore, Smith, Ouellette-Kuntz,
and Green (2018) found that women in general, face further disparities while men with
IDD were more likely to receive age-appropriate screening than women with IDD.
Parish, Swaine, Son, and Luken (2013a) used medical records from 2006-2010 to
identify women with IDD aged 18-65. They found that women who had an obstetrician/gynecologist and who lived in residential facilities in rural communities had higher rates
of CC services than other women with disabilities, necessitating improvement of CC
screening services and awareness for this population. Hospital discharge rates among
women treated for incidences of uterine cancer were found to be higher than those of CC,
according to Parish et al. (2018). Women hospitalized for CC treatment stayed longer,
were younger, and the majority were on public insurance for healthcare.
Leser (2016) and Cobigo et al. (2013) provided the foundation that promotion of
health behaviors for PWD is lacking and that direct service professionals (DSPs) and
support groups need to be educated on the promotion of health behaviors for the
implementation and intervention services that reduce disease incidences, including CC
(Parish et al., 2018). Individualistic, person-centered reviews are warranted for a good
understanding of what is occurring to prevent disease prevalence among PWD. However,
the fear of violating the rights of PWD keeps DSPs from promoting health, nutrition, and
physical activity, and it manifests itself as a significant barrier (Leser, 2016).
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Campbell (2017) asserted that nutrition plays a significant role in cancer
development, despite the complexity of multistage etiology. Because of the way cancer
develops, there is room for nutrition to either slow the disease or contribute to it. Cancer
occurs in three stages, according to Campbell and Campbell (2016). The first occurs
when a carcinogen is introduced into the body, which leads to the development of cancerprone cells that develop into masses, the second stage, which then leads to metastasis, the
third stage (Campbell & Campbell, 2016). A whole-food, plant-based diet offers the most
nutritional value in cancer reduction, according to Campbell and Campbell, while
nutrition and healthy lifestyles were advanced by Campbell and Campbell to be the next
frontiers of medicine given that poor lifestyles and nutrition are related to higher disease
risk.
Zam and Khadour (2017) noted that cellular signaling is changed by epigenetics
related to a high-fat, high-calorie diet while Del Cornò, Donninelli, Conti, and Gessani
(2017) found that red-meat combined with the consumption of processed foods increases
cancer risks. Physical activity, according to Davies, Batehup, and Thomas (2011), lends
itself to better outcomes for cancer reduction, mainly because low body weight decreases
disease risks.
Fisher and Howell (2010) offered that empowerment and self-efficacy improve
outcomes. Teitelman et al. (2011), using the theory of planned behavior (TPB), provided
a technique for use in focus groups to determine perceptions of cancer prevention. Stacy
et al. (2016) advanced that when people had a goal related to their behavior, outcomes
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were realized within a given timeframe. Education that is tailored to intervention toward
improved healthy lifestyles is also an important variable for this study (Spector, 2009).
From a broader perspective, HealthyPeople.gov (2020) has noted that health data
for PWD that informs public policy so as to support programs that tackle disparities is a
problem, calling for the inclusion of standard disability items in health data surveillance
instruments. Effective health and wellness programs applicable for PWD is a problem,
hence HealthyPeople have called for the introduction of evidence- and community-based
strategies in health promotion, and, public infrastructure and universal designs that t
ensure that professionals who work with this population are appropriately trained to meet
this population’s health care prevention and treatment needs (HealthyPeople.gov, 2020).
This current study aligned with these issues and hoped to meaningfully contribute to one
or more of these areas as noted by HealthyPeople.gov. In summary, prevention measures
that include screening, engaging in healthy behaviors, gaining health education, a
disability competent workforce, and including PWD in health data surveillance
instruments are all efforts to improve services, thereby reducing CC prevalence and
mortality.
This current study was needed because, despite the growing body of research
available pointing at the health disparities for this population, none had examined the
relationship of CC for this population in KY using inpatient and outpatient discharge data
after cancer treatment. A Healthcare Cost and Utilization Project study that used 2010
data from discharges linked cancer treatment to younger women with disabilities and
longer hospital stays (Parish et al., 2018) for this population. Parish et al.’s (2018) study
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was based on 30 women diagnosed with both CC and IDD and 21,635 women with CC
without a disability from the 2010 data. It is important to re-state that PWD are invisible
in data, and the numbers may have been limited due to identifying standard elements not
being imbedded in data used by Parish et al. (2018). It is also worth noting that the study
did not include outpatient treatment services data, although research trends show a shift
from inpatient to outpatient cancer treatment.
This current study captured women diagnosed with CC living with disabilities
that could potentially be receiving radiation and chemotherapy in settings that offer
outpatient services. In KY, there was no population-based study found that addressed CC
prevalence from secondary data in a way that specifies the characteristics of women
discharged from the treatment of reproductive cancers to account for population-specific
differences. This study stepped to the plate and filled that gap. This current study was
important as it contributed to learning about CC relative prevalence in KY noted in the
discharges of women receiving reproductive cancer treatment. The emphasis on CC was
due to the growing rates of CC prevalence in KY, and because CC can be eradicated by
vaccinations, screening and appropriate timely treatment for precancerous lesions or for
the invasion of CC according to World Health Organization (WHO; 2019a).
Problem Statement
CC has persisted as one of the leading causes of death around the world and is,
unfortunately, the fourth most frequent cancer, representing 6% of all cancers among
women (WHO, 2019a). In 2018, 570,000 new CC cases were estimated, according to the
WHO. In 2020, the American Cancer Society (ACS; 2020b) estimated that 4,290 women
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would die, while 13,800 new cases of invasive CC were estimated. Early detection
through effective screening, prevention, and treatment are strategies to eliminate CC, and
while vaccinations are available to reduce the risk of disease, CC incidences and
mortality persist. From the most recent data (2015), for example, KY’s incidence of CC
was 8.8 per 100,000, with mortality of 2.7 per 100,000, with higher rates in Appalachian
KY, which was a noted increase from 2014 data (ACS, 2020a).
In KY, according to the CDC (2020b), the overall prevalence of all disability
types for those 18 and older is 35%. KY women experience higher rates of disabilities
than men (37.3% versus 33%), which translates to about 677,681 KY women (CDC).
Women with an IDD are a vulnerable population, typically requiring lifelong support
(Knox, 2008). People with IDD live longer, are being diagnosed with cancer earlier in
life, and, when compared to the general population, depend on public funding (i.e.,
Medicare, Medicaid) for their healthcare needs (Parish et al., 2018). There is scrutiny for
more innovation and more efficient processes of purchasing that define the health care
delivery system for PWD (Anthes, 2018). A value-driven system that includes the
reduction of CC incidences and better health outcomes is emerging in public health, with
the responsibility of, among other things, ensuring health equity that adds to quality
community inclusion for women with IDD (Drum et al., 2009).
IDD is defined as a limitation that significantly affects the intellectual functioning
as well as the behavior adaptation affecting social and physical adaptations of daily living
(American Association of Intellectual and Developmental Disabilities [AAIDD], 2019).
IDD usually occurs before age 18, and mostly occurs at birth, affecting such body
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systems as the nervous system, sensory system, and metabolism (National Institute of
Health, 2016). People with IDD are siblings, friends, neighbors, employees, parents,
students, and community members, and the diagnosis does not imply a reduction in the
right to thrive in health or to have an engaged and active life (Hewitt & Nye-Lengerman,
2019). There are several risks in the physical comorbidities faced by this population,
namely obesity, cardiovascular disease, diabetes, and cancer, to name a few (Haveman,
Heller, Maaskant, Shooshtari, & Strydom, 2010). In addition to these risks, this
population has been shown to have higher rates of disease incidences, while the use of
healthcare services has not been consistent with set guidelines, especially for the
screening of colorectal, breast, and CC (Ouellette-Kuntz, Coo, Cobigo, & Wilton, 2015).
Disability, on the other hand, is a term that is broadly used around the world to
refer to a mental, physical, sensory, or intellectual impairment of a person (Drum, et al.,
2009). Different cultures interact with disability differently. Disability, according to
WHO (2020), contains three dimensions: impairment, activity limitation, and
participation restriction. The International Classification of Functioning, Disability and
Health (ICF) offers a standard language that helps to classify the three dimensions,
mainly used for qualification purposes in the health decisions for service and supports.
According to ICF (CDC, 2020c), activity and participation that are hard to define are
included in the following categories:
•

Learning and applying knowledge

•

Managing tasks and demands
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•

Mobility (moving and maintaining body positions, handling and moving
objects, moving around in the environment, moving around using
transportation)

•

Managing self-care tasks

•

Managing domestic life

•

Establishing and managing interpersonal relationships and interactions

•

Engaging in major life areas (education, employment, managing money or
finances)

•

Engaging in community, social, and civic life

Although much progress in overall services has been noted in this population,
adults with a disability in KY and in the United States in general continue to experience
tremendous health-risk behaviors and health characteristics compared to adults without a
disability (Havercamp, 2017). Recognized risks in this population, according to Dixon
(2015), include, but are not limited to: inactivity, physical comorbidities, low
understanding of risks, poor hygiene, obesity, and sexual victimization, all factors that
increase CC risk. In addition to these risks, according to Parish et al. (2013), only 55% of
the women with IDD aged 18-65 years old received pap screenings during 2008-2010,
which is below the target rate of 93% set from a baseline of 84.5% by HealthyPeople.gov
(2014).
Furthermore, extensive research on barriers to screening for CC, breast, or colon
cancer have also been noted, and despite early screening being identified as integral for
higher survival rates (Kilic, Tastan, Guvenc & Akyuz, 2019), women with disabilities are
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still at a higher risk of dying from reproductive cancers and more specifically from CC
than women without disabilities (Parish et al., 2018). These barriers can be categorized in
domains that include cost, transportation, health literacy, lack of expertise and attitude of
healthcare providers, prior negative healthcare experiences, health care access to include
tools and lack of environmental adaptations to meet the needs of this population, referral
patterns, and psychosocial factors (Akinlotan, et al., 2017; Magasi, et al., 2019; Merten et
al., 2015; Reis, et al., 2015; Todd & Stuifbergen, 2012 & Yankaskas, et al., 2019).
Despite the extensive research on barriers, disparities, and the growing cancer
prevalence for this population due to living longer and better supports, very little has
been done around health disparities from hospital data. Two studies in the United States
(Lezzoni et al., 2008 & Parish et al., 2018) and one in Australia (Sullivan & Hussain,
2008) looked at hospital trends and outcomes, treatment options for this population, as
well as reproductive cancer treatment hospitalizations using inpatient data. However,
there are no studies that have looked at the relationship between CC and women living
with disabilities in KY as evidenced by both inpatient and outpatient hospital data. This
study examined the population-based specific health factors of CC and women with
disabilities in KY to potentially develop or increase targeted interventions for this
population (Parish et al., 2018).
Purpose of the Study
The purpose of this study was to quantitatively examine the relationship between
CC and women with disabilities as evidenced by medical records. Secondary data from
the KY IHD and OSD datasets were used. This database holds data variables including
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(a) admission source; (b) primary and secondary procedures and diagnosis; (c) patient
demographics (age, gender, county of residence, race and ethnicity); (d) hospital type and
location; (e) service payment source; (f) length of stay, if admitted; and (g) patient status
that includes discharge status details that can be used for this study’s examination. This
current study was important because it explored the relationship between CC and women
with disabilities as evidenced by discharges from inpatient and outpatient treatment for
women with disabilities strategically comparing population-specific differences from a
Social Determinants of Health (SDOH) framework (Solar, 2010. Furthermore, this study
contributed to the possibility of empowering women with disabilities so that they may
overcome barriers to both screening and healthy behaviors to reduce CC mortality and
morbidity rates (Orji, 2016). This study may potentially inform policy on health
disparities for this population through health equity advocacy. Interventions to increase
screening and prevention need to be tailored to the specific needs of the population at
hand, for example, insufficient nutrition, exposure to infectious diseases, and trauma
(Park, Kim, Yang, Lee, & Park, 2018). Well informed support for PWD is important for
advocacy upon attendance of regular visits to a physician, all issues that render
themselves to prevention measures. Lived experiences of women with disabilities would
add greatly to the advocacy and strength of influencing preventive measures as well as
treatment equity.
Research Questions
The following research questions guided this study:
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RQ1: Is there a statistically significant relationship between IHD status of woman
(with or without disability), payer type, age, county of residence, , and diagnosis of a CC?
H01: There is no statistically significant relationship between IHD status of
woman (with or without disability), payer type, age, county of residence, and
diagnosis of a CC.
Ha1: There is a statistically significant relationship between IHD status of woman
(with or without disability), payer type, age, county of residence, and diagnosis of
a CC.
A similar research question was used for the outpatient services data to capture
those women discharged from outpatient care.
RQ2: Is there a statistically significant relationship between OSD status of woman
(with or without disability), age, county of residence, and diagnosis of a CC?
H02: There is no statistically significant relationship between OSD status of
woman (with or without disability), age, county of residence, and diagnosis of a
CC.
Ha2: There is a statistically significant relationship between OSD status of woman
(with or without disability), age, county of residence, and diagnosis of a CC.
Conceptual Framework for the Study
This study used the SDOH framework that draws its foundation from many
researchers, most notably Diderichsen. In 1998, Diderichsen and Hallqvist introduced a
model that framed disease as a production from a social outlook, and this was adopted as
a health inequality mechanism by Diderichsen, Whitehead, and Evans (Solar, 2010). The
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model initially emphasized the pathway through social position and health risk exposures.
This model was then elaborated to emphasize mechanisms that result in health outcomes
that are stratified, which include
Those central engines of society that generate and distribute power, wealth and
risks and thereby determine the pattern of social stratification. The model
emphasizes how social contexts create social stratification and assign individuals
to different social positions. Social stratification, in turn, engenders differential
exposure to health-damaging conditions and differential vulnerability, in terms of
health conditions and material resource availability. Social stratification likewise
determines differential consequences of ill health for more and less advantaged
groups (including economic and social consequences, as well as differential
health outcomes per se). (Solar, 2010, p. 23)
Add summary and synthesis to fully integrate the quote into the paragraph and to develop
a conclusion for the paragraph.
The current SDOH theory as used by epidemiologists has three main directions.
The first is the political economy of health or the social production of diseases (Solar,
2010). The second is the psychosocial approaches, and the third is the eco-social theory
with multilevel frameworks according to Solar. These three directions are not mutually
exclusive, but rather seek to find underlying explanations for health inequalities in
society. The three directions cannot be reduced to mechanisms, or rather cannot provide
causation. They differ in the emphasis they lend to biological or social conditions that
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shape target populations and in the recommendations that they provide (Solar, 2010).
Chapter 2 offers a more in-depth explanation of this theory.
With the foundational connection between contextual settings and the individuals
that live in them being susceptible to disease due to different factors, there is the need to
identify the origin of differences that cause disease. It is appreciated, however, that the
individuals may not be affected in the same way by contextual effects (Duncan, Jones, &
Moon, 1998). This framework provided an appropriate foundation for this study in that it
offered a means for between-individual and between-context variables to offer an
explanation of the origins of the health inequalities faced by women with disabilities,
paving the way for a multilevel analysis regression analysis that was able to address the
complexities involved. This framework was able to answer the research questions that
drilled more in-depth into the complexities of women living with a disability in KY.
Nature of the Study
The nature of this research was an observational, quantitative study based on the
discharge of women with a disability from a reproductive cancer treatment (that includes
CC) as the unit of observation in comparison to the discharged women without a
disability. This study was also of a cross-sectional type, consistent with providing a
snapshot of the relationship between CC and women with disabilities. An examination of
discharge patient status provided characteristics that shed light into the origins of CC
among other reproductive cancers. The data from the Kentucky Cabinet for Health and
Family Services (KCHFS) IHD and OSD was helpful in the examination of this study.
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In using the SDOH framework, the interdependence of distal and proximal
variables was used in a way that considered both the reductionistic and purely ecological
variables for a more sufficient explanation of the underlying origins of CC within this
population. A multilevel analysis with the ability to interface the proximal (individuallevel) and distal (group-level) variables (Szklo & Nieto, 2019) was used, providing a
means to interpret the body of evidence more clearly (Duncan et al., 1998).
The independent variables for this study included (a) the status of discharged
women, i.e. whether or not they had a disability, (b) age of the woman, (c) county of
residence, (d) insurance payer type (as an indication of socioeconomic variable), and (e)
patient status as it related to living conditions. In accounting for the population
composition, the dependent variable for this study included the diagnosis of reproductive
cancers, which included CC. In addition, due to the need for reliable estimates for
individual and group-level variables, there was a need to have “many individuals from
many places” (Ducan, Jones, & Moon, 1998, p. 113) for a precise assessment and to do
useful work.
Secondary data was downloaded from KCHFS. This data was collected from
inpatient and outpatient information and was aggregated as a discharge database for KY
hospitals and health service providers. IHD data records every single utilization of
service at an ambulatory facility, while the outpatient information (OSD) records a
patient visit, not an admission to a hospital. The data was appropriate for outcome
analysis and research (KCHFS, 2017a).
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The SDOH framework used for this study recommends use of a multilevel
analysis for the benefit of accounting for the individual- and group-level variables while
dealing with the complexities of the data. Multinomial logistic regression (MLR) was
used to both frame and test CC’s variability and contextuality (see Duncan, Jones &
Moon, 1998). Although a multilevel analysis can use the individual-level variables, I
used the discharge as the unit for analysis, not the individual patient, due to privacy
concerns. The idea behind this study is that “factors operating at the levels of groups or
societies affect the health of individuals within them” (Diez-Roux, 1998, p. 221). It was
with the possibility of incorporating other appropriate analytical strategies, that this
multilevel analysis would contribute to the SDOH framework to strengthen public policy
recommendations.
Definitions
The following terms were used in the understanding of incidence prevalence of
reproductive cancers with more emphasis on CC for women with disabilities.
Developmental disability: This is a severe, chronic disability that is attributed to a
mental or physical disability or a combination of mental and physical disabilities and is
manifested before the age of 18 and is likely to continue indefinitely (Hewitt & NyeLengerman, 2019). Such disability has a result of substantial functional limitations in
three or more of the major life activities, namely self-care, learning, mobility, receptive
and expressive language, self- direction, the capacity of independent living or economic
self-sufficiency according to Hewitt and Nye-Lengerman.
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Disability: The CDC (2020c) definition of disability was paraphrased for this
study. Disability is an impairment, or any condition of the mind or body that restricts the
person from doing certain activities (activity limitation) or restricts their participating in
activities in their environment.
Health: This study used the definition of health as developed by WHO in 1948:
“A state of complete physical, mental and social well-being and not merely the absence
of disease” (WHO, 2019c, para. 1).
Health disparity: The HealthyPeople 2010 definition was used for the purposes of
this study: “Differences that occur by gender, race, or ethnicity, education or income,
disability, living in rural localities or sexual orientation” (Drum et al., 2009. p. 137).
Incidence: Incidence measures new disease occurrence and describes the
transition to disease from health. The type of incidence referred to in this study was the
incidence rate captured when new cases of disease arise during a person-time of
observation and it is a true rate (Aschengrau & Seage, 2014).
Intellectual Disability: “Intellectual disability is a disability characterized by
significant limitations in both intellectual functioning and in adaptive behavior, which
covers many everyday social and practical skills. This disability originates before the age
of 18” (Hewitt & Nye-Lengerman, 2019, p.1).
Prevalence: This is a measure of existing disease and focuses on the period when
someone is ill and measures the proportion of the total population diseases at a point in
time or for a period of time (Aschengrau & Seage, 2014).
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Reproductive cancers: For the purpose of this study, IHD and OSD were
restricted to the five cancers of interest, also referred to as reproductive cancers which
included cancers of the cervix, ovary, uterus, breast, and other female genitals (vulva,
vagina, fallopian tube; National Institutes of Health, 2018).
Person-centered supports: Supports that implement "person-centered planning,
which is an ongoing process directed by an individual and others chosen by the individual
to identify the individual's unique strengths, interests, abilities, preferences, resources,
and desired outcomes as they relate to the individual's support needs” (Ohio Department
of Developmental Disabilities, 2019).
Social determinants of health (SDOH): “The complex, integrated, and
overlapping social structures and economic systems that are responsible for most health
inequities. These social structures and economic systems include the social environment,
physical environment, health services, and structural and societal factors. SDOH of health
are shaped by the distribution of money, power, and resources throughout local
communities, nations, and the world” (CDC, 2020h para 2). In short, SDOH are the
“social, economic, and political resources and structures that influence health outcomes”
(Drum et al., 2009, p. 132).
Assumptions
The assumptions of this study were that incidences of CC among other
reproductive cancers do occur within the women with disabilities demographic in the
population and that the goals of treatment would be for healthy outcomes and cancer
survivorship. Given the high rates of CC in KY among the general population, it was
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assumed that CC rates among women with disabilities would be high as well. Another
assumption was that cancer screening for women with disabilities was not occurring as
recommended, given the health inequalities experienced by this population. This would
mean that cancer rates would be higher for this population. It was also important to
assume that some women were diagnosed at later stages for reasons that may include, but
not be limited to, noncompliance with screening information, misdiagnosis, lack of
access to health services, or missed appointments.
PWD are served and supported by many organizations, as well as by family
members. The need is great for the message about screening for cancer to be assumed to
have been shared at several levels and points where services for this population are
offered. Screening as a secondary prevention is important to be understood by women
with disabilities as well as their circles of support. Another important assumption was
that awareness of health disparities for women with disabilities and the persuasion that
screening and treatment for reproductive cancers are important for everyone, would lead
to organizations implementing health strategies that ensure healthy outcomes for this
demographic.
Scope and Delimitations
I examined the incident prevalence of CC among other reproductive cancers from
a population-based perspective. Secondary data from KCHFS was used, and because of
the issue of women with disabilities being invisible in the data, it was necessary to
include a review of reproductive cancers as opposed to merely CC for a clearer picture. A
population-based perspective allowed for an examination of reproductive cancers for
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women with and without disabilities, allowing for generalizability of findings. The data
represents patient discharges from all hospitals in KY that offer cancer services. Hospital
data was an excellent choice as it is an actual reflection of services provided.
The ages of interest for this study were 21-74-years-old. Previous studies noted
that women with disabilities are diagnosed at an early age with a form of reproductive
cancer (Satgé et al., 2014) and that, because PWD are living longer, chronic diseases are
more prevalent (Parish et al., 2018). That this study has a population-based approach
allows for generalizability. There is a need to include women with disabilities in
comparison to women without disabilities. If data had been available, comparing these
demographics in the population by different cancer types would contribute to the
determination of deeper further need for more specific targeted interventions. The results
are based on a population-based approach and offer a more valid argument for women
with disabilities in comparison to those without.
Limitations, Challenges, and Barriers
Some potential barriers of this study included the fact that secondary data,
although an efficient means of research, requires extensive clean up due to missing data
or a lack of data appropriate for research (Cheng & Phillips, 2014). The more years of
data used, the more complex the analysis and data cleanup required. It was necessary to
use several years of data to obtain an appropriate sample for this study. The secondary
data included a fee for data access, a confidential agreement for data ownership, and a
secure server for data storage. Upon thorough review of the data variables, the study
design and data analysis changed for a more appropriate analysis and to ensure valid
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results. The use of the MLR method helped limit some of the limitations of secondary
data.
Administrative data at the state-level offered a quality source of research that
involves people with disability. The context added to such efforts offer an avenue for
critical evaluation of disability services at a state level (Wilkinson, Lauer, Greenwood,
Freund, & Rosen, 2014). Health surveillance for PWD presents several challenges
starting with caseness and a definition that clearly operationalizes the meaning of
disability. Different definitions lend themselves to differing prevalence rates and perhaps
overlapping of people in data (Havercamp & Krahn, 2019). Another challenge lies in
finding people with IDD in the data due to national data not allowing for respondents
with disabilities. While administrative data can be used for surveillance of disability
health, many people may not be in the administrative data as they live with their families.
KY maintains databases that capture women with disabilities, and this offers an
opportunity to tailor an examination of reproductive cancer services as well as the impact
of interventions in place in the DD system in KY.
Significance
This study was significant because community inclusion for PWD must include
the breakdown of barriers to such healthcare services as prevention, screening, and
treatment for reproductive cancers, as well as eliminating health disparities for this
population. Health and wellness must include knowledge that educates those with
disabilities as well as those that care for them on the risks associated with CC, as well as
the need for prevention, early detection, and treatment (HealthyPeople.gov, 2014). The
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results of this research provide much-needed insights into the processes that can increase
screening and health behaviors for women with disabilities in KY as well as provide the
impact status of intervention strategies in place to meet the disability and health goals set
by Healthy People 2020. The is growing emergence of the need to demonstrate value for
money spent in Medicare and Medicaid, to ensure the demand is met for quality services,
and perhaps to evaluate of the need for a surveillance system that addresses healthcare
outcomes for women with disabilities (Fujiura, Li, & Magana, 2018).
The results of the research findings offer facts that can inform policymakers and
DD professionals that desire to fully include people within their communities of the need
for inclusive quality services in prevention, screening, and treatment. Including a
demographic of PWD in research allows for a true picture of services and costs of
healthcare for better planning and budget allocations. The results of the study will also
offer information for continued advocacy for activities that promote accessibility and
decrease health disparities that exist in cancer prevention for this population.
The positive social change significance includes advocating for increased quality
health services that ensures equity and ameliorates health disparities among women with
disabilities regarding CC and other reproductive cancers. This includes involving PWD in
research and in the target interventions, educating PWD, their families, and medical
professionals, public health practitioners as well as those who advocate for people with
IDD. I hoped to refocus attention from just health prevention among the DD community,
to the adoption of services geared toward that of increased promotion of health for this
population from an integrated approach. This may help to ensure discussions in
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community inclusion for service and supports include reproductive cancer screenings so
as to lessen the disparity in cancer outcomes, especially for those with IDD (see Drum et
al., 2009; Parish et al., 2018). Social change that diffuses adherence of secondary
preventive strategies to attain set guidelines in prevention and screening for better
outcomes is a positive change in public health not only for women with disabilities, but in
the communities in which they live. Understanding the origins of CC for this population
and offering appropriate recommendations for consideration for public policy is a next
step to social change.
Summary
It is evident that despite technology advances and improved person-centered
supports, PWD are experiencing chronic diseases such as cancer. PWD have other health
care needs not common to people without disabilities that could be compounded by
chronic illnesses. To meet the needs of this demographic in the population, it is important
to consider the conditions in etiology that leads to poorer health outcomes. Associated
health conditions, secondary conditions, and comorbid conditions must be distinguished
for health impact that matters most for this population. This quantitative study sought to
identify the origins of CC among other reproductive cancers using data from KCHFS for
women with and without disabilities for identifying the differences. The characteristics of
these women were examined for an in-depth insight into the health conditions.
In Chapter 2, relevant literature is discussed, and the key words were CC,
reproductive cancer, breast cancer, IDD, disability, CC and breast screening, CC
prevention, nutrition, and health behaviors. Chapter 3 describes the methodology used
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for the study and the research questions to be answered, together with the variables to be
used. Chapter 4 will describe the data collection, analysis, and the results of the analysis.
Chapter 5 will follow with an interpretation of the results, limitations, recommendations,
and implications of this study.
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Chapter 2: Literature Review
Introduction
Although CC screening programs have been in place for many years, CC
continues to claim many lives and is the fourth leading cause of mortality among all
cancers, accounting for 6% of all cancers among women (WHO, 2019a). Inequalities
persist in the adoption of early screening for CC, which perhaps affects regular screening
participation (Hahm et al., 2011). SDOH have been shown to determine CC screening
rates with more socioeconomically disadvantaged women participating at lower rates
leading to higher mortality rates among this population. More educated women typically
have higher CC screening rates while African-American women have typically lower
screening rates and, by extension, higher rates of CC incidences according to Hahm et al.
In reviewing healthcare use data, Ouellette-Kuntz et al. (2015) found CC screening
services for African-American women do not meet federal screening guidelines among
other types of cancers.
The challenges for CC screening access appears compounded among women with
a disability. In KY, there are 677,681 women among the 37.3% of the population living
with a disability (CDC, 2019b). This population is more at risk for disease due to such
factors as inactivity, comorbidity, and the dependence on lifelong supports. PWD are less
likely to be included in mainstream classrooms or to attend college, find competitive
employment, visit their neighbors and make neighborhood meaningful connections in
their neighborhoods, use technology in ways that benefit their health, receive prevention
services and access fitness facilities, or to obtain health services appropriate to their
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needs. Krahn (2019) indicates that the health outcomes of adults, especially those with
IDD, are poorer due partly to their limited access to health and wellness programs and
health care, but also because of a combination of the SDOH factors.
The purpose of this quantitative study was to examine the relationship between
CC and women with and without disabilities in KY as evidenced by medical records.
This study identified gaps that can be addressed to reduce health disparities for this
demographic and may contribute in a small way towards public policy, and advocacy for
surveillance programs for this population that is unified and linked (see Krahn, 2019).
Both inpatient and outpatient data from KY were used to examine the relationship
between (a) socioeconomic factors embedded in the county of residence and CC status
for women with disabilities, (b) level of disability as measured by diagnosis and CC
screening status, (c) age and payer of health services, and (d) hospital discharge status of
the women that identifies their living environments. The KY cancer registry would have
been used as needed to verify that rates of women with a cancer diagnosis and a disability
were captured accurately. Although persons with a disability typically are not well
represented in the data, it was not necessary to link data across several data sources to
arrive at a more accurate representation of women with disabilities, although that was
great planning (see Lin et al., 2014).
This literature review begins with a description of search terms and techniques to
inform the researcher of current CC screening data both nationally and in KY. The
study’s theoretical framework is then presented with a discussion to its application. This
is followed by a review of the key variables and SDOH that impact CC screenings rates
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among women with disabilities. The chapter concludes with an introduction to the
methodological approach to be used in this study.
Approach to the Literature Review
This section explains the methods used to explore the relationship between CC
and women with disabilities in KY. The literature search was limited to quantitative
studies, CC, women with disabilities, and SDOH framework. Keywords used to identify
studies for review included CC, CC screening, IDD, CC prevention, nutrition and health
behaviors, disability in public health, and health disparities for women with IDD.
Searches were conducted at the Walden Library databases for dissertation both from
ProQuest and globally and for articles in the Cumulative Index of Nursing and Allied
Health Literature and Medline databases. The American Association on Intellectual and
Developmental Disabilities (AAIDD) database also was used. Literature had to be
published at least within 5 years, but not older than 10 years. A few literature options
older than 10 years were used due to their quality of contributions, and since there was a
lot more recent literature, they gave a well-balanced foundation to the review.
Most of the studies reviewed dealt with CC, breast cancer, ovarian, and uterine
cancers, with a few specifically addressing the women with an IDD. A substantial
amount of studies addressed the impact of protective factors, such as nutrition, healthy
behaviors, and others on the reduction of risk factors for CC. CC etiology was addressed
by a few studies, addressing most of the CC epidemiology. Regarding CC screening
within the general population, literature was plentiful, although not so for the population
with IDD. The role of support, self-determination, and person-centered services was
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addressed by a few articles. Very few studies were found that focused on the
administrative data used to identify CC screening and prevention services among women
with disabilities. Several articles identified the lack of surveillance programs of this
population as a major challenge. One article and one dissertation were found that
successfully link the SDOH framework to cancer studies for people with IDD.
Conceptual Framework
Social Determinants of Health Framework
The SDOH framework, according to WHO (2019b), draws most of its
contributions from several researchers, primarily from Diderichsen and Hallqvist’s model
of disease production developed in 1998 as identified in Chapter 1. Other prominent
researchers of the SDOH framework include Evans and Whitehead and their
interpretation of health inequality mechanisms (Solar, 2010). According to WHO, a
comprehensive framework should, as follows –
i)

Identify the social determinants of health and the social determinants of
inequities in health;

ii)

Show how major determinants relate to each other;

iii)

Clarify the mechanisms by which social determinants generate health
inequities;

iv)

Provide a framework for evaluating which SDOH are the most important
to address; and,

v)

Map specific levels of intervention and policy entry point for action on
SDOH. (Solar, 2010, p. 20)
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This framework as used in this current study had the ability to identify the
determinants related to the reproductive cancers after a multivariate analysis. As noted
above, the SDOH framework was a great foundation that was able to address the
between-individual and between-context variables in a way that identified some
differences between women with and without disabilities. Given all the complexities
possible, this framework had the capability of guiding this study to meaningful results.
Solar (2010) argued that while it is impossible to fit all the elements into a single
framework, several components must at least be considered. First among these is that
theories of power impact action upon social determinants. For determinants of health to
change, those in power must be willing to guide action in a way that distributes power to
benefit the less advantaged. Power from “a relation in which people are not dominated
but empowered through critical reflection leading to shared action” is desirable for
meaningful social change (Solar, 2010, p. 21). The second component is that social
position carries with its underlying mechanisms that stratify outcomes for the population.
According to Solar, the most important stratifiers in society include occupation,
education, social class, race/ethnicity, and gender. These SDOH inequities are the root
causes of health inequities. In addition, there are intermediary determinants brought about
by socioeconomic position, all of which influence health. These intermediary
determinants include psychosocial, biological, and behavioral circumstances; and,
material circumstances, such as housing, work, and neighborhood situations.
From the CDC (2020h), one way to summarize these intermediary determinants is
to consider that “conditions in the places where people live, learn, work, and play affect a
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wide range of health risks and outcomes” (para. 2). WHO (2019b) reiterated and
broadened this explanation by stating people are born, grow, live, work, and age in
conditions that are shaped by power, distribution of money, and resources at a global,
national, and local level, causing differences in health at all these levels (WHO). This
information is summarized visually in Figure 1 which shows the socioeconomic and
political determinants that have an impact on equity, health, and well-being.

Figure 1. Social determinants of health conceptual framework. Adapted from
Solar O, I. A. (2010). A conceptual framework for action on the social determinants of
health. Social Determinants of Health Discussion. Paper 2. Policy and Practice.

Similar Application of SDOH
Opara (2017) used the SDOH framework in an investigation of male breast cancer
(MBC) with a purpose of uncovering the underlying predictors of MBC by looking at
age, grade of cancer, and race as the predictors of the outcome of MBC mastectomy.
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Opara’s interest in the SDOH framework lay in seeking to understand how factors
interacted with social determinants in the occurrence of MBC and its discovery as it is a
very rare disease. While Opara did not find the grade of cancer to be significant
predictors of MBC, she did find that race and age were significant predictors among
white men diagnosed with MBC. Opera offers a great example of how the SODH can be
used to identify determinants that are associated with a type of cancer, in this case, the
MBC.
In another study, the population of Victoria, Australia, was compared using
population data to measure the health and wellbeing of the citizens (Haider, Ansari,
Vaughan, Matters, & Emerson, 2013). A total of 897 adults with ID and 34,168 people in
the general population were used as the sample for the comparison of health outcomes.
The SDOH framework revealed that poor social determinants of health were more
prevalent among people with ID, as were depression, poor or fair health, and behavioral
risks. People with ID were also found to have higher blood pressure and blood glucose
levels, and that people with ID had lower CC and breast screening rates compared to the
general population (Haider et al., 2013). It is important to note that the differences noted
in the population was possible because those with ID were regarded as a subgroup in the
general population and the SDOH offered a great framework.
In reviewing the 2014 Behavioral Risk Factor Surveillance System (BRFSS) data
and the type of health insurance used for the payment of cancer screening, it was clear
that disparities occur by health insurance status and insurance type (Zhao, Okoro,
Dhingra, Xu, & Zack, 2018). Although the study by Zhao et al., did not involve adults
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with IDD, it was nevertheless framed by SDOH framework. Another study on cancer
cost-of-care aimed to identify barriers, including psychosocial and financial factors, and
their effects on care among cancer survivors aged 65 and older (Banegas et al., 2018).
Factors identified included medical care, amounts owed, financial hardship, cancerrelated variables, and caregiver status. The study by Banegas identified key insurance and
financial risk factors that were barriers to receiving medical care among cancer survivors
aged 65 and older. Those with financial hardship were less likely to receive medical care.
As a patient’s debt increased, the likelihood a patient received medical care declined even
further. Survivors without insurance or caregivers or who were less likely to understand
their medical bills did not receive the necessary medical care according to Banegas.
(These studies provide an application of the SDOH framework and its ability to identify
those influences on health outcomes. In such manner, the SDOH had the ability to
identify the variables or determinants of health relating to reproductive cancer outcomes
in the current study.
How SDOH Relates to this Study
I considered other theories for my study, including the health belief model, which
attempts to predict why and whether people take action in the prevention, control, and
detection of disease due to perceived susceptibility, severity, barriers, and benefits of
engaging in a particular behavior when given relevant cues to action (see Glanz et al.,
2015). However, the theory was dropped due to the limitation of the measurement
variability of the theory’s central constructs and the availability of secondary data. A
second theory, the socioecological model, was considered due to its ability to conduct a
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multilevel study of determinants for more effective interventions. According to Glanz et
al. (2015), the socioecological Model can expound on relationships between community,
social factors, health, individuals, and physical environments. I ruled out this model,
however, due to its inability to explain which variables contribute most to behavior that
influences successful interventions. A third theory, the theory of planned behavior, used
focus groups to identify cancer prevention perceptions as described in Teitelman et al.
(2011). However, as a quantitative study, this approach would not have aligned with the
methodology. A fourth theory, diffusion of innovation (Boston University, 2019), was
considered, yet, at the proposal stage, it became apparent that it was not well aligned with
the study and it was dropped.
The SDOH offers a framework from which to examine the individual and group
differences in a population at a multilevel analysis without compromising the validity of
results. In this study, I considered the discharge status of women with IDD diagnosed
with CC as the unit of analysis, and because of the complexities that can bring, a
multilevel analysis was preferred. The SDOH framework aligns well with this type of
statistical complexity (Diez-Roux, 1998; Duncan et al., 1998;). In addition to the
analysis, it also became clear that women with IDD experience greater health disparities
than the general population. The SDOH framework was fitting as it offered the
opportunity to engage more deeply into the complexities of disparities and to offer new
opportunities and insights that may ameliorate these disparities (see Drum et al., 2009).
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Literature Review Related to Key Variables
Key variables for this study included disability in public health, IDD, CC
screening status, health disparities and health equity, residential options for women with
disabilities, the role of DSPs, natural supports and professionals, the role of nutrition and
health behaviors and administrative data. The following section addresses these variables
from the literature review perspective.
Disability and Public Health
HealthyPeople 2020 called attention to disability and the need to include
disability in all health systems that collect data to uncover and reduce health disparities to
achieve health equity (HealthyPeople.gov, 2014). PWD have historically been
overlooked in issues regarding their health status and disparities, even in routine health
services like CC screenings. Disability has historically not been regarded as a partner of
public health, but as a health outcome, a minority population, or a social factor (Drum et
al., 2009), and since healthcare professionals are not typically well equipped to address
the disparities in this population, or the health challenges for this population, the women
with more severity of disability tend to experience lower cancer screening as well as
other health disparities (Horner-Johnson et al., 2014). Even though in the United States
the age-adjusted prevalence for any disability in 2017 was estimated at 26 % (CDC,
2020c) and that in general about one out of five people are living with a disability (U.S.
Census Bureau, 2018), there are still few medical care providers, specialists and
professionals that are well trained to confidently treat and work in public health settings
for population-specific service deliveries that reduce disparities of health.
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In KY, persons with disability comprise 35% of the population compared to the
national average of 25.6% (CDC, 2020b). The disability status encompasses the highest
percentage as those with a mobility disability at an estimate of 20.2 %, followed by those
with a cognitive disability at 16.1%. Those with an independent living disability are at
10.2 %, hearing impaired are estimated to be at 8.3% while those with a self-care
disability are at 5.7%, a little less than the visually impaired at 6.1%. According to the
CDC, the Veterans with any disability are estimated at 39.3 % as compared to nonveterans with a disability estimated at 34.2% . Women are represented in all these
categories with a total estimated at 37.3% while men are at 33%. Figures 2 and 3 offer
more details on disability data available for KY within the CDC’s Disability and Health
Status Data System (DHDS) (CDC, 2020b).

Figure 2. Disability status by age group in Kentucky, 2017. From Behavioral Risk Factor
Surveillance System (BRFSS; CDC, 2020b).

Achieving quality cancer care is important to reduce inequities for women with
disabilities. Excellent communication among support professionals and medical
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professionals is key in ensuring timely cancer care from prevention to diagnosis, to
treatment (Kemp, 2019). The disability estimates above with the addition of Figure 2 are
evidence that the estimates of those living with a disability represent a substantial target
of the population in KY regarding public health challenges and opportunities. Disease
prevention and interventions from a disability epidemiological design is possible through
systemic inquiry into processes, distribution, patterns, determinants and disabling
outcomes in populations (Drum et al., 2009). A disability may be examined as a
population-specific subspecialty for the prospect of disease and death prevention for this
population (Aschengrau & Seage, 2014). Public health planning, design, and
implementation without considering this population can be detrimental to the whole.
It is difficult to determine disability incidence since various etiologies give rise to
disabling conditions. Disabilities arise in the perinatal or neonatal periods, others from
genetic or congenital alterations, others from chronic conditions, traumatic injuries while
yet others arise from etiologies that are unknown (Drum et al., 2009). Some disabilities
arising from time-limited discrete events like birth or traumatic injuries are relatively
easy to identify and to have an incidence calculation. But incidences from chronic
diseases that take a long time to develop are hard to detect. Historically, high disability
prejudice has resulted in more institutionalization. Cohesive advocacy has led to fewer
people in institutions; however, this could be at the expense of health equity (Friedman,
2019).
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Figure 3. Disability types by race/ethnicity, Kentucky, 2017. From Behavioral Risk
Factor Surveillance System (BRFSS; CDC, 2020b).
Disability has been conceptualized in three different models or approaches as
explained by Drum et al. (2009), namely the medical, functional, and social models of
disability. The medical approach relies on the description that disability is a result of
being “sick” resulting in the need to be “cured” by adhering to a medical prescription
regiment that includes treatment and interventions. Disability is therefore viewed as a
health outcome and is measured by morbidity and mortality with failure being regarded
as failure in prevention (Drum et al., 2009). The functional approach relies on disability
being the inability to perform several functional activities. A third approach is the social
model that insists that a person has a disability due to the barriers within the environment
that include physical, social, political, and economic dimensions. Each of these
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approaches determine how a person with disability is treated and supported in the
community.
Newer approaches to disability, according to Drum et al. (2009), include the need
to view disability as a demographic, because disability in population health comprises a
subgroup with large and unexplained differences in health outcomes. Disability as a
mediating factor between impairment and health, social determinants shows that
disability discrimination contributes to health disparities with lost opportunities towards
health equity. When disability is addressed from a SDOH framework in public health, it
provides a mechanism that drills deeper into complex health disparities for PWD,
creating new roles and opportunities for public health per Drum et al. (2009).When
professionals are not educated on the SDOH, service needs and gaps exist in the care
received by people with IDD. Increasing knowledge among public health professionals is
key to reducing disparities among women with IDD in CC cancer and in general. Public
health professionals owe it to women with IDD to find ways to reduce health disparities.
CC success in KY requires intentional interventions to this population. As the population
ages, disability increases, requiring the shifting of funding to meet the needs of an aging
population, among those with and without a disability. Figure 3 indicates the disability
types of those 18 years old and above by race/ethnicity. It is imperative that disability
status be included in public health data, in healthcare settings, and in administrative data.
Intellectual and Developmental Disability
It is important to understand disability, and especially IDD more so as a
foundational knowledge base for this population demographic. This study recognizes

41
there is a need to discuss people with disability while distinguishing between the
disability types as previously discussed in the disability section. Depending on the cause
of the disability, health insurance differs for these subgroups, as does the delivery of
health services. This study was not able to distinguish the subtypes of disability, however
disability in the data encompassed all types of disability and the study recognizes that
some people have Intellectual Disabilities (ID) while others have Developmental
Disabilities (DD), and some have both.
In addition to a previous definition of IDD, it can be added that IDD is a severe,
chronic disability that is attributed to physical, cognitive, or a combination of the two, as
manifested usually before age 18 with the likelihood of continuing indefinitely (Hewitt,
Nye-Lengerman, 2019). IDD mostly occurs at birth affecting body systems like the
nervous system, sensory system, metabolism, and degenerative systems (National
Institute of Health [NIH], 2016). While this type of disability was impossible to identify
in the data, it is such a huge disparity as this demographic needs to be represented in
population specific public health agenda.
In most cases, a person qualifies for IDD services when their functional
limitations are identified to be in seven key areas, namely limitations in; Self-care,
Receptive and Expressive Language, Learning, Mobility, Self-direction, Capacity of
independent living, and Economic self-sufficiency (Hewitt & Nye-Lengerman, 2019).
The limitations in these areas have historically dictated the kinds of supports and services
required for a person with IDD to function in their environment (Parish, 2001). These
services are usually life-long and are directed by person-centered service planning.
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Examples of Developmental Disabilities (DD) include spina bifida, autism, cerebral
palsy, and ID (Hewitt & Nye-Lengerman, 2019). Persons with ID are further classified
according to the corresponding intelligence quotient (IQ) levels as follows: mild ID (IQ
of 50-55 to approximately 70); moderate ID (IQ of 35-40 to 50-55); severe ID (IQ of 2025 to 35-40); and, profound ID (IQ below 20-25). In 2010, the definition of ID changed
(AAIDD, 2011). Disability is “characterized by significant limitations both in intellectual
functioning and in adaptive behavior, as expressed in conceptual, social, and practical
adaptive skills. This disability originates before the age of 18” (AAIDD, 2019, para. 1).
This definition change was largely in part due to the need to create better pathways to
identifying the appropriate service and support need for each person with an IDD
qualified for home and community-based services (HCBS). According to Luckasson and
Schalock (2013), a functional approach of IDD classifications offers a holistic human
being view with a language that is common, offering opportunities for flexible
approaches to supports and services that are effective with meaningful outcomes.
The corresponding levels of support changed to be intermittent for episodic or 'as
needed' supports and from a framework of what is important to/for a person with IDD
(Hewitt & Nye-Lengerman, 2019). Limited supports are needed on a regular basis for a
time limited period. Extensive supports are on a regular routine involvement for some
environments (e.g., daily). The last type of support is the pervasive, which are constant
and high-intensity supports provided across several environments and potentially lifesustaining in nature. These levels of support are needed in HCBS to include community
employment, health, and safety and for social activities supported with Medicaid HCBS

43
waivers. From Friedman (2019), HCBS waivers offer an opportunity to “waive key
provisions of the Social Security Act to create and expand community long-term services
and supports particularly tailored to populations that would typically require institutional
care” (p. 264). The change to the service model seeks to impact services in education, to
improve social roles, and to support self-determination.
Early childhood and school years require equally sophisticated planning.
Furthermore, as youth enter adulthood, a lot of the information previously known can be
lost in the transition. Transition planning for youth entering adulthood requires
multidisciplinary professionals, which would include primary care physicians. However,
individual and systemic barriers keep them from being involved (Dressler, Nguyen,
Moody, Friedman, & Pickler, 2018). On the other end of the spectrum is the fact that
women with IDD are represented in geriatric oncology, which is a subspecialty that is
evolving in oncology. Women over 65 are underrepresented in clinical trials, which
results in dilemmas of treatment for this population and, due to health inequality, even
more so for women with IDD. Morbidity rates among the elderly lead to suboptimal
treatments requiring the use of options that are contemporary surgical measures to reduce
post-operative morbidity (Venkatesulu, Mallick, & Rath, 2017).
People with IDD experience more health challenges when compared to their peers
with no disabilities. They have comorbidities that include cardiovascular disease,
diabetes, obesity, psychiatric disorders, and gastrointestinal disorders among others.
People with IDD are living longer, and they are therefore presented with geriatric issues,
and with the absence of screening at recommended rates , the risk of disease is higher as
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are the challenges in old age for this population, especially increased morbidity. A
Finland study found that cancer incidence among people with IDD was quite comparable
to that of the general population despite some low unhealthy behaviors like smoking and
decreased screening rates. However, PWD were at higher risk for some types of cancer
(Patja & Iivanainen, 2001). In fact, some conditions that lead to ID have been associated
with higher incidences of cancer such as Cowden syndrome, down Syndrome, PraderWilli, Angelman Syndrome and fragile -X. Birth defects have also been identified to
indicate higher risks of cancer, and with the increased life expectancy, people with IDD
are living longer, resulting in more chronic conditions among this population according
to Patja and Livanaine (2001). Clear guidelines and tracking processes can assure that
people with IDD receive screening at recommended rates, preferably even at a higher rate
than people without disability (Brown, Jacobstein, Yoon, Anthony, & Bullock, 2016),
especially due to the increased health risks already mentioned.
Cervical Cancer Screening Among Women with IDD
The U.S. Preventative Service Task Force (USPSTF) recommends CC screening
every 3 years via cervical cytology for all women between the ages of 21-29. USPSTF
also recommends high-risk HPV (hrHPV) screening every 5 years and hrHPV testing and
cervical cytology testing every 5 years for all women between 30 and 65 years old
(USPSTF, 2018). Screening is not recommended for women who have had their cervix
removed. These recommendations are meant for all women, with or without a disability.
In addition to recommendations like those above, women with an IDD deserve
continuous improvement of their daily living conditions, not only for quality community
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living, gaining employment in the community, but also in gaining access to appropriate
health in all its technologies and assistive technologies (HealthyPeople 2020). As
indicated by the Surgeon’s General Call to Action, women with an IDD are leading
healthy and long lives due to increased community inclusion and access to health care
and the availability of professionals that know how to support this population
demographic (Drum et al., 2009).
Women with IDD were less likely to have increased screening even with
improving continuity of care and this has resulted in less than enough screening rates
(Plourde et al., 2018). Studies have found that disparities exist for women both with
disabilities and those without. In fact, the screening for breast and CC for both sets of
women have been consistently below the Healthy2020 goals, with women with
disabilities falling shorter, and more so for those women with more complex disabilities
(Horner-Johnson et al., 2014). It has also been noted that in the United States, women in
urban areas, especially in the northeast have higher rates of screening. In the United
States, rural disparities, lower screening, and high levels of mortality have been
associated more with the south (Horner-Johnson et al., 2014). Secondary prevention is
hard for people with IDD mainly because they may not fully understand nor have the
information, nor identify disease signs and symptoms. When only 22% of people with
IDD in a two-year period participate in periodic health physical examination as compared
to 26.4% for people without IDD, it is clear health disparities exist. When screening does
not happen as recommended for gender and at age-specific periods, it puts this population
at increased cancer risk (Ouellette-Kuntz et al., 2015).
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When primary care physicians were asked about pap smear screening for women
with IDD, 90 % of them expressed the need for women with IDD to get screened
regularly. Public healthcare settings were more confident and prepared, and those with
rapid screening capabilities and follow up reminder processes and systems were more
confident in their ability to screen this population. Lin et al. (2010) added that those who
felt this screening was needed, believed there was a need to set up a special screening for
this group of women. This set up, however, would need to be well thought out as perhaps
that could be viewed by many as creating a non-inclusive setting. Lin et al., found that
72.5 % of the medical facilities offered pap smear services and 51.5% had the experience
of screening women with IDD (2010). Lin et al., also noted that women with ID had
trouble and pain with the pap-test. It is no surprise that physicians seem unequipped, nor
aware of the needs of the women with the more severe needs. This may be attributed to
perhaps never been exposed to this demographic during their professional training. The
discomfort that women feel during screening can be too much for any women to handle,
leave alone when that is piled up with IDD or other type of a physical disability. Most
physician offices may not have accessible examination tables for a good majority of this
demographic.
Despite the great improvement of services for PWD, screening for women with an
IDD has continued to lag that of women without a disability (Parish et al., 2018). Most
physicians and caregivers overlook screening for this population due to the perception
that these women are less sexually active (Brown et al., 2016). With increased
community integration and more advocacy, women with IDD have had increased sexual
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relations, especially with the movement to de-institutionalize and more people moving
into smaller group homes or congregate sites for community inclusion (Hewitt &NyeLengerman, 2019). More and more individualized service plans indicate educational
needs for safe sexual relations. Furthermore, according to a survey conducted in 2012,
over 70% of those people living with a disability reported as having been abused of
which 41.6% was reported as sexual abuse (Baladerian, Coleman, & Stream, 2014).
Since most of these may not be reported for fear or lack of knowledge to do so, etc,
delays in appropriate services including CC screening may be of negative outcome.
Furthermore, even when women with IDD have been noted to be sexually active through
a known pregnancy, the uptake for CC screening has still been noted to be lower (Brown
et al., 2016). The service delays in ensuring screening may also be due to lack of
coordinated efforts to communicate to the medical professionals, hence the disconnect.
Diagnosis has tended to be made at later stages of cancer progression for this
population leading to unfavorable outcomes. Age and level of education have been
significantly associated with CC screening rates (Park et., 2018). In linking cancer
hospitalization to women with IDD, Parish et al. (2018) found CC hospitalization was
less prevalent for women with IDD at 2% as compared to that of women without a
disability at 4% (2018). Although these percentages are not large, it is prudent to note
that the data used was for inpatient hospitalizations and does not include services
provided at cancer outpatient clinics or health facilities, and especially in a way that
compares CC prevention, screening and treatment of women with disabilities from a
sociodemographic manner. There is a need for educational campaigns on CC screening as
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well as the elimination of risks that are associated with CC (Ebu, Mupepi, Siakwa, &
Sampselle, 2015) and more specifically in the IDD population.
Hospital discharges for women with IDD were associated with higher uterine
cancer incidences and lower incidences for CC. The discharges were higher for younger
women with IDD who experienced longer hospital stays utilizing public insurance
(Parish et al., 2018). Adenocarcinoma in situ (AIS) and cervical intraepithelial neoplasia
grade III (CIN III) Surveillance) is necessary for determining strategies for preventing
disease. Data from the years 2009 - 2012 from the population-based cancer registries was
analyzed by age, histology and race for Michigan, Louisiana, KY and Los Angeles. The
highest rates of CIN II/AIS at 69.8% were found in KY followed by Michigan at 55.4%
then Louisiana at 42.3%, and Los Angeles at19.2%. The authors found that generally, the
rates went lower for the younger aged women likely as a relation of screening
recommendations and more human papillomavirus vaccinations (HPV) intake (Watson et
al., 2017). KY had the highest rates of CIN II/AIS, which may imply that women with
disabilities may be highly represented in that number, due to the noted lag in screening.
Lee, Shin, Hwang, and Lee, (2017) studied breast and CC screening behaviors of
cancer survivors and found that breast cancer screening rate was 56.6%, higher than that
of non-cancer survivors or of CC screening at 51.4%. The low screening for CC can be
explained by the non-recommendation for CC screening for women who have undergone
a total hysterectomy, although CC survivors were likely to get a CC screening ten years
after diagnosis. Lee, Shin, Hwang, and Lee did not find sociodemographic to be
associated with cancer screening and perhaps looking at factors beyond
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sociodemographic was required for comprehensive planning of screening behaviors
(2017). Women with IDD may have similar breast cancer incidence as women without
IDD, however, they have lower mammogram screening rates and higher breast cancer
mortality (Greenwood et al., 2014). Although such disparities occur, women with IDD
experience inequalities in access to screening for cancer. According to Cobigo et al.,
(2013), women with IDD who do not get mammography are one and a half times more
than women without IDD, and twice as many that do not receive CC screening.
Receiving screening as recommended helps to identify health problem signs early,
affording any patient the opportunity for treatment and hopefully avoiding starting
attention prior to health-threatening stages of breast and CCs. There are many barriers to
secondary prevention for breast and CC (Swaine, Parish, & Luken, 2013). Some of these
barriers according to Merten et al., include income, education, employment, history of
screening, age tobacco use, geographic location, disability level and activity level (2015).
When the cancer was not detected early, it resulted in tumors with higher stages
according to the American Joint Committee on Cancer (AJCC), for younger women with
IDD even when histological types and tumor grade may not have been significantly
different. Women without IDD had less advanced tumors discovered at later ages than
women with IDD (Satgé et al., 2014). It is apparent that women with IDD deserve the
right to have breast and CC (BCC) screening as early as women without disabilities for
better health outcomes.
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Cervical Cancer Screening in Kentucky
From the Cancer Action Network (CAN), women diagnosed with CC have a 92%
5-year survival rate compared to a 99% 5-year survival rate among women diagnosed
with breast cancer (CAN, 2019). CAC indicates that many of the women not receiving
screening are uninsured and low-income or underinsured (CAN, 2019). Since the IDD
population is largely insured by public insurance, this indicates some may fall through the
cracks, or do not as stated earlier, receive screening as recommended and are in fact
experiencing screening disparities as captured in the CAN statistics. Twenty states exceed
CAN’s goal of ensuring no woman is left uninsured or denied cancer screening due to
appropriating $1 in-state funds for every $3 in federal funds. Four states—Hawaii,
Vermont, KY, and South Dakota—missed the opportunity to fund early detection
programs. This may be an area for policy advocacy impact from this study, for timely
strategic planning that puts KY in a position of ensuring no woman is left unscreened.
With the high rates of CC in KY, a partnership collaboration may offer great advocacy.
CC has been explained with contextual-level information making it important to
ameliorate effects of contextual effects for increased health equity. Targeting socially
deprived areas is a strategy that would assure progress toward health equity (Lin, 2014).
From the CDC’s BRFSS data, women with disabilities receive CC screenings at rates
lower than those without a disability based on 2018 data (2020b). BRFSS data was
compared from 2016 to 2018 prevalence rates for CC screening in KY. It was evident
that women with disabilities received CC screening at a prevalence rate of 74.7%, a rate
lower than the national US, DC and territories rate of 77% in 2016. 2018 data revealed
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that women with disabilities had a similar trend (75.5%) in KY as compared to 78.1%
nationally in the US, DC and territories. The CC screening prevalence in KY for women
with no disabilities was higher than the national rates for both years at 86.6 % and 85.8 %
respectively as shown in Table 1. There was a slight increase in screening rates in KY for
women with disabilities while that of women with no disabilities went down slightly.
Table 1
Cervical Cancer Screening Among Females 21 to 65 Years of Age by Any Disability
Status
Any

No Disability

Disability

Any

No

Disability

Disability

2016

2018

USA, DC & Territories

USA, DC & Territories

Prevalence (%)

77

83.7

78.1

83.9

95% CI

75.9-78.1

83.1-84.2

77.1-79.1

83.3-84.4

Weighted No.

10,778,066

44,276,164

12,826,235

48,698,632

Kentucky

Kentucky

Prevalence (%)

74.7

86.6

75.5

85.8

95% CI

69.5-79.3

84-88.8

69.6 - 80.6

83 – 88.3

Weighted No.

205,924

579,504

222,286

566,272

Adapted from CDC’s Behavioral Risk Factor Surveillance System (BRFSS). (CDC,
2020b).
It was helpful to review the prevalence of CC screening rates in KY by age from
the BRFSS for any type of disability. Table 2 reveals the age specific information on the
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prevalence of CC screening for 2016 and 2018. The 2016 data indicates that the age with
the highest CC screening was ages 21- 35 (78.9%) followed by ages 51- 65 (73.8%). For
2018, the age group with the highest CC Screening was 21- 35 (81.5%), followed by the
age group 35 - 50 (77.6%). Data shows there was an increase in screening for women
with disabilities in KY for these age groups in regard to actual weighted numbers,
although disability rates were also noted to have increased.
Table 2
Comparing Kentucky Cervical Cancer Prevalence Rates Among Women with Any
Disability by Age
Age

21 - 35

35 - 50
2016

51 - 65

21 - 35

USA, DC & Territories
Prevalence 76.9

35 - 50
2018

51 - 65

USA, DC & Territories

81.2

73.7

77

82

76.2

79.5-82.8

72-75.4

75.1-78.9

80.2-83.6

74.6-77.8

4,279,496

3,796,431

4,750,309

(%)
95% CI

74.5-79.1

Weighted

3,375,397 3,458,343 3,944,417

No.
Kentucky
Prevalence 78.9

Kentucky

72.1

73.8

81.5

77.6

68.3

(%)
95% CI

66.7-87.5

60.8-81.2

68.4-78.6

67.9-90.1

68.8-84.5

59-76.4

Weighted

60,279

66,004

79,642

79,570

69,045

73,670

No.

Adapted from Behavioral Risk Factor Surveillance System (BRFSS). (CDC, 2020b)
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The CC screening in KY in 2016 had a similar trend nationally in the US,
however in 2018, KY screening rates beat the national rates for ages 21 – 35, but lag for
age groups 35 – 50 and 51 – 65. It is important to understand that cervical cancer is a
disease that progresses over time. Although the BRFSS data was collected at the same
time as the KCHFS IHP and OSD data was being collected, it is hard to correlate the two.
Without the ability to link the data, and by using the discharge as the unit of analysis it is
difficult to pinpoint and identify the progression of disease for specific intervention
strategies. It is important, however, to acknowledge that CC screening is happening and
although KY may lag in some age groups, from a national perspective, CC screening
interventions are occurring in KY, for both women with and without disabilities due to
statewide strategic interventions.
The most recent 2018 BRFSS data as noted by CDC (2020b) indicated that the
prevalence for CC screening by disability is as follows: a) cognitive disability (80%), b)
hearing disability (76.3%), c) mobility disability (72.7%) and d) vision disability
(68.4%). By disability type, the 2016 BRFSS data showed that the CC screening
prevalence for a) cognitive was 72.4%, b) Hearing 76.1, c) mobility (74.9%) and d)
vision at 73.2%. Those with cognitive and hearing disabilities had an increase in
screening, while those with mobility and vision disability types had a decrease in CC
screening (CDC, 2020b).
Health Disparities and Health Equity
According to the CDC (2020a para.1), health disparities are “preventable
differences in the burden of disease, injury, violence, or opportunities to achieve optimal
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health that are experienced by socially disadvantaged populations.” According to
Friedman (2019), as a whole, PWD are among the most socioeconomically
disadvantaged populations, leading to ways in which they are discussed and
characterized, perhaps diffusing their health disparities despite the movement from
institutions to community-based living arrangements.
Whether a person with a disability has access to a public or private health plan is
another way in which to explain the health disparity facing this population. In KY, 14.3%
of persons with a disability in the Appalachian region receive disability benefits, a rate
higher than the U.S. population as a whole (5.1%) and higher than KY residents from
non-Appalachian regions (6.8%) (Appalachian Regional Commission, 2017). With
respect to cancer mortality rates, Appalachian KY cancer death rates are 35%, a rate
which is also higher than that of the nation as a whole and of non-Appalachian KY
residents. The health of Kentuckians is affected by SDOH that affect where people live,
learn, work, and play. Poverty limits access to healthy food while more education and
safe neighborhoods are predictors of desirable health outcomes (CDC, 2020i). Applying
known facts about SDOH improves the health of all people, including women with
disabilities. HealthyPeople 2020 recommends a framework that is location-relevant in
addressing health disparities in order to implement initiates that are effective in bringing
about healthier outcomes and greater health equity (HealthyPeople.gov, 2014). These
initiatives are best through collaborations across sectors to best ensure diffusion of
information, initiatives, and, more to the purposes of this study, CC screening (Ridgeway,
2018). HealthyPeople 2020 organizes the SDOH into five categories: health and
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healthcare; economic stability; neighborhoods and built environments; social and
community context; and education (2014). It was from the lens of these five categories
that this study addressed the relation of CC with women in KY.
Bollinger et al. (2018) used principal component analysis to rank KY’s counties
into quartiles based on such variables as poverty rates, educational attainment, social
associations, environmental conditions (water and air quality), and healthcare providers
(Figure 4). Central and Western KY counties had the best outcomes, while Eastern
counties fared less favorably in terms of health outcomes. The map was a useful
reference for identifying county of residences for the discharged women with or without
a disability.

Figure 4. Social determinants of health by Kentucky county. Source: Bollinger, Hoyt,
Blackwell & Childress (2018).
Research has demonstrated that disparities in healthcare services occur to PWD as
a result of such access barriers as inadequate education, inadequate training among
healthcare professionals, and discrimination (Gibbons, Owen & Heller, 2016). Hall and
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Kurth (2019) compared survey data for Americans with IDD, those with Autism
Spectrum disorder (ASD), and those with other disabilities. Although all three groups
were found to have poorer overall health and less access to healthcare services compared
to people without disabilities, those with IDD and ASD reported different outcomes and
experiences than those with other disabilities. This necessitates further examination
among persons with IDD or ASD, especially with respect to CC screening so as to inform
policies and target interventions for these populations (Hall & Kurth, 2019).
From the research, persons with an IDD face health care service disparities in the
form of inadequate education, prejudice and discrimination, access barriers, and
inadequate health professional training. This then means there is a gap in the way that
supports and strategizes the needs of people with IDD. Gibbons, Owen, and Heller (2016)
studied the perceptions of health and health of people with IDD and found that this
population defined good health as “(a) absence of pain, disease, and symptoms, (b)
adherence to or not requiring treatment, (c) physical self-care, (d) mental or spiritual selfcare, and (e) ability to perform the activities one wants to do. Participants conceptualized
healthcare as (a) ensuring needs are met through access to services, (b) obtaining quality
services, (c) navigating the healthcare system successfully, and (d) receiving humanizing
healthcare” (p.1).
Women with an IDD who have had a pregnancy are more likely to: be young, to
live in neighborhoods that are low income, live in the rural, and have high morbidity
rates. According to Brown et al. (2016), women with an IDD are screened less even when
they have had a pregnancy and are known to be sexually active, pointing to a need for
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requiring equitable screening levels as persons without a disability. This health disparity
could very well be due to the disconnect of information between the medical physician
world and that of people with IDD.
While women with an IDD experience breast cancer at the same rate as women
without a disability, breast cancer screening rates are much lower among women with an
IDD. Greenwood, Dreyfus, and Wilkinson (2014) conducted a qualitative study with XIV
family members, which revealed certain themes into the differences in perspectives
between women with an IDD and those without. Although women with an IDD are
valued family members, a mammogram represented several challenges for loved ones,
including: a) that families needed to acknowledge sexuality and all that this may mean for
an adult female family member with an IDD, b) come to terms with a cancer diagnosis, c)
quality health, which did not necessarily include screening. This whole process was
feared because facing screening may necessitate difficult conversations and decisions
that needed to be made, but decisions that family members were not ready to make, or did
not want to make.
In a similar study of examining perspectives from caregivers who were women,
Swaine, Dababneh, Parish, and Luken (2013) found that caregivers did not believe or
know that screening was needed. Preparation prior to the exam was the most common
factor mentioned by the caregivers as causing a huge barrier of screening. Other
perspectives included knowing the risks and signs and symptoms but having lived
through negative experiences, lack of educational materials, attitudes, physical and
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emotional attributes, all challenges that add up as barriers to screening for this
demographic (Taggart et al., 2011).
It is important to note that strategies for breaking bad news of cancer to women
with IDD and their families are inadequate. Open communication and best practice
models are needed to support this population (Tuffrey-Wijne, Bernal, & Hollins, 2010).
Because most people with IDD depend on caregivers, communication would be best
when tailored to the train the trainer perspective, affording time to process best way to
communicate to each person with IDD in the most specific and effective way to each
individual.
In reviewing differences between breast cancer and CC screening from a
disability severity perspective, Horner-Johnson et al. (2014) analyzed Medical
Expenditure Panel Survey data from 2002-2008. What they found was that although
differences were great for women with disabilities, those with more severe complexities
fell even shorter of the HealthyPeople 2020 goals. After controlling for geographic,
demographic, and socioeconomic factors, Horner-Johnson et al. (2014) found that
disparities for CC screening remained significant unlike that of mammography. For
comparison, data from 2008-2009 showed that 29% of African-American women as
compared to 59% White women received mammographs. When model covariates were
included, the persistent racial disparities were noted (Parish, Swaine, Son, & Luken,
2013a). In looking at other population groups, Adeyemi, (2013) found that education
level, family income and age-associated significantly with CC screening for women
living in the U.S. after emigrating from Africa.
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Residential Options for Women with Disabilities
The push toward community integration among people with IDD finds many
women with IDD living in assisted, residential group homes in the community (Hewitt &
Nye-Lengerman, 2019). Well-functioning teams within a residential unit are bound to
have quality patient safety and the implementation of quality services, to include timely
physician appointments and screenings for women with disabilities (Suchman, 2011).
Among women residing in residential group homes, there is the potential for them to
remain invisible to current health care data surveillance systems due to the fact that this
population might not be recognized in the larger population and that residential
characteristics of people with IDD may not match the survey options of data collection
(Krahn, 2019). With only 60% of community-dwelling people with IDD identified in the
data, poor planning in public health services is an obvious, though unfortunate, outcome.
Parish et al. (2018) linked hospital discharge statistics with place-of-residence
among women with disabilities and showed most such patients were younger, more than
likely from poorer neighborhoods, on public insurance programs, and had lengthier
hospital stays. Parish, Swaine, Son and Luken (2013b) used 2006-2010 medical records
to identify CC screening rates among women with IDD aged 18-65 and who lived in
primarily rural residential facilities. They found that women who had an
obstetrician/gynecologist had higher CC screening rates than women with IDD who had
no obstetrician/gynecologist, necessitating improvement of CC screening services and
awareness for this population. It is important to empower women to overcome CC
screening barriers and, by extension, reduce overall mortality and morbidity rates (Orji,
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2016). Interventions to increase CC screening and prevention efforts that are tailored to
specific needs of women with IDD regardless of the place of residence do well in
increasing equity for this population (Park et al., 2018).
The sub-population of people who live in residential, 24-hour group homes or
congregate sites had better representation in administrative data than those who lived
independently or with family members. Administrative data kept for tracking client
health and improving communication between providers indicated a low false-negative
cancer rate as compared to hospital data (Wilkinson et al., 2014). Massachusetts requires
service providers to keep and maintain up-to-date electronic health records.
Representation is important, and administrative data had very high representation.
Women who lived at home with family and family caregivers surprisingly exhibited the
most limited CC and breast cancer screening knowledge and awareness (Parish, Swaine,
Luken, Rose, & Dababnah, 2012). This is an area that may require creative interventions
to raise awareness and health literacy.
Leser (2016) and Cobigo et al. (2013) provided the foundation that promotion of
health behaviors for people with IDD is needed and that DSPs and support groups need to
be educated on the need for implementation and intervention that leads to fewer disease
incidences (Parish et al., 2018). Well-informed support for people with IDD is important
for advocacy and for clear articulation of status while on a physician regular visit. When
care staff were asked about cancer engagement regarding supporting people with IDD for
prevention and promotion of health, most staff indicated they had not received any
training on cancer prevention, nor had they received any information on family histories

61
on cancer for those they cared for. Although women with ID were reported to have higher
body weights than their male counterparts, which poses a higher risk for developing
cancer (Hanna, Taggart, & Cousins, 2011), care staff were not aware of the relation
between higher body weight and cancer and the need to maintain a healthy weight.
Horner-Johnson et al. (2014) found pap testing was not accounted for by
socioeconomic, geographic, or insurance variables as was breast cancer screening by
mammography. Training that is on-going for staff that work in disability systems is
needed to improve communication especially with healthcare primary providers,
Education for staff on the importance of early screening as well as the collection of data
that is accurate (Brown et al., 2016). It is of utmost importance that women with
disabilities are supported to understand the need to acquire primary care as well as why
early health screening is important for them.
Caregiver perspectives reveal the need to understand insurance utilization, the
benefits of continuity of care, the need for clear communication among physicians,
women with IDD and caregivers, the need to have women with IDD buy-in to health
equity, and the need to prepare professionally to work with this population (Erickson,
Salgado, & Tan, 2016). There is a positive impact by the patient-centered medical home
in increasing health screening due to proper incentives and strategies (Dixon, 2015).
Cost
Healthcare costs for people with IDD have differences in mixed pattern service
rates. Second, from prescription medicine, the highest cost utilizer, secondary chronic
diseases and poor mental health were the highest predictors of across the board high
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expenses of health care (Fujiura et al., 2018). There are those that think that since disease
rates may be less among women with IDD, it is not cost-effective to invest in screening.
For example, less than 1% of women with down syndrome were found to have breast
cancer among data for 684 women with 2 % up-taking breast cancer screening. There are
those that question if this is a cost-effective and beneficial effort (Chicoine, Roth,
Chicoine, & Sulo, 2015). Most people with IDD may utilize public insurance, however,
the percentage that uses private insurance makes insurance payer an important variable to
study (Krahn, 2019).
Use of Administrative Data
Women with disabilities are invisible in the data, making it important to leverage
linking datasets to borrow from the strengths of different data sets. Chronic conditions
have been identified to be affecting cost and use as well as render greater risks due to
high obesity levels in this population. It is critical that PWD are visible in data for quality
healthcare in terms of monitoring and healthcare delivery as well as costs and policy
(Fujiura et al., 2018). Databases can be linked to population-based research as well as for
identifying people with IDD as identified in studies from Canada and Australia.
Infrastructures need to be created to leverage data linking for research that
impacts policy to the benefit and support of people with IDD and their health and wellbeing (Balogh et al., 2019). Common surveillance methods for acquiring prevalence for
people with IDD include a review of administrative data, population-based surveys and
public health surveillance. Administrative data that analyzes claims from Medicaid and
Medicare offers an opportunity to understand the health status of a large population by
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conducting surveillance that utilizes brevity, simplicity and uniformity (Reichard et al.,
2019). The current study used KCHFS data as it contained both the Medicaid and
Medicare variables, affording the opportunity to explore the relation of CC and women
with and without disability in Kentucky.
When PWD have been asked about their perspectives on healthcare, they have
indicated better results than what people without disabilities would have perceived as not
good. Themes that emerge from PWD’s perspective on good health are: not needing
treatment, or stable conditions, absence of pain, disease, and symptoms, ability to engage
in activities of choice, spiritual or mental care and physical self-care (Gibbons, Owen &
Heller, 2016). These perspectives complement the need to uncover more from
administrative data.
In as much as administrative data is important, it is not able to identify: barriers to
screening from lived experiences by PWD, healthcare providers quality of
communication, poor communication and coordination of care, communication status
between PWD and physicians, or between physicians and issues relating to policies and
procedures or non-compliance to recommended screenings (Erickson, Salgado, & Tan,
2016). This type of examination may be best acquired through a qualitative methodology.
Administrative data at the State-level offer a refreshing source of avenue for
research into the IDD population. The context added to such efforts offer an avenue for
critical evaluation of IDD services at a state level (Wilkinson et al., 2014). KY maintains
databases that capture women with disabilities, and this offers an opportunity to tailor an
examination of CC screening services as well as the impact of interventions in place in
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the DD system in KY. Self-reporting for both cervical and breast cancer are generally
overreported by women with IDD, just like for women without a disability (Son, Parish,
Swaine, & Luken, 2013). Self-reported data does require corroboration with other data
sources for more accurate results.
It is not surprising that health data that includes disability offers the opportunity to
examine CC for women with an IDD to inform services towards quality care and also for
financial accountability. According to Andresen et al. (2013), most studies have not
agreed on the definitions of disability, making it hard to pinpoint what disparities exist
for women with disabilities. The federal government has supported administrative data by
subgroups (for example race and gender), however, there have not been policies requiring
data of disability by status making it hard to study this population at a deeper
epidemiologic level, from secondary data. With the little data available that states
disability status, women with Multiple sclerosis (MS) have been identified as with
effective disparity while pap tests have significantly declined as functional ability
declines among women with a disability (Andresen et al., 2013).
Another area of data for this type of study is population-based cancer registries,
figuring out how best to compare the women with disabilities represented in the
registries, to those found in IHD and OSD. According to Tucker (2019), important
scientific and technical advances have occurred in the population-based cancer-registries
that include but not limited to refinements in natural language processes (NLP), linking
records using probabilities, genomic sequencing performance. Studies based on such
registries can provide external validity strength. The use of cancer registry data offers an
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opportunity to use a scientifically representative underlying population. This may not
always be possible per Tucker with Hospital data, especially data from hospitals without
multidisciplinary cancer programs (2019). Central cancer registries are a good source of
data that is well representative of a population-based sample that provides external
validity that can confidently be generalized. Cancer registries can also provide evidencebased guidance for the implementation of quality services (Tucker et al., 2019).
Linking KY cancer registry data with information from inpatient and outpatient
discharge-from-care data makes for an interesting variable in the effort to contribute to
the determinants of health data (Krahn, 2019). Issues such as why a patient population
may be visible in one system and not the other, along with health outcomes, may help to
educate clinicians, the public, and other stakeholders on more specific barriers—and
opportunities to overcome those barriers—within the SDOH framework. It is clear that
interoperability while difficult to achieve due to the current infrastructure in health
records, can be improved and linked to personal health records to allow for more accurate
information (Akubuiro, 2018). For this to be designed more cohesively, a uniform
standard is needed for the collection and sharing of data among organizations. This will
require the good will or well-informed people in power to distribute the benefit by
empowering organizations to improve interoperability for meaningful social change in
the world of data sharing (Solar, 2010).
Educating Women with Intellectual and Developmental Disabilities
Education is a major component within the SDOH framework to address health
disparities. When women seek knowledge of CC from different reputable sources,
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increased preventative behaviors are likely to occur (Habtu, Yohannes & Laelago, 2018).
Women with IDD can be encouraged to advocate for access to CC screening for reduced
morbidity, mortality, and costs associated with CC (Oriji, 2016). Cancer screening
sessions aimed at increasing awareness and benefits of screening have shown increased
knowledge on the importance of screening while reducing anxiety. Women age 35 to 44
years have been noted to have a heightened fear of cancer (Cullerton et al., 2016).
Women were noted to not have undergone screening because they did not believe they
were at risk, they had no symptoms, and they did not know where to go or they feared
examinations.
Studies have shown that women with IDD have retained information on
screening, however, an increase in the knowledge about breast cancer and CC screening
is needed, especially for CC as the knowledge is lower than it is for breast cancer.
Receiving care can be blocked by lack of understanding (Swaine, Parish, Luken, Son, &
Dickens, 2014). It is clear that increasing the knowledge base for women with IDD, their
families and caregivers are key areas to address for screening rates to increase and for
disease incidences and mortality to reduce. Providers that adhere to screening rates need
to be acknowledged even with incentives (Susan, Jamie, Esther, and Karen, 2013).
In addition to women learning about why it is important to screen early for CC,
their knowledge base can be expanded on a person-centered approach to include
knowledge on other reproductive diseases, to include but not limited to breast, ovarian,
uterine and even colon cancers. Cancer, as Campbell (2017) asserts, is a complicated
disease consisting of multistage and multifactorial etiology, thus requiring multifactorial
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strategies, in all the stages that involve prevention, screening, diagnosis and treatment.
According to Campbell and Campbell (2016), cancer occurs in three stages, namely the
implantation of a carcinogen into the body, the promotion of cancer-prone cells that
develop into masses over a long time, and then metastasis occurs causing death. Nutrition
can promote or slow down cancer stages despite the complexity of multistage etiology.
Prevention education for cancer must include the fact that nutrition is important, and this
same message must be shared with women with IDD, the DSPs, families and
stakeholders that support them. A high risk for numerous neoplastic diseases is that of
inappropriate dietary/nutrition and a change in these habits can reduce the risk of cancers
(Wołoszynek, Stępnik, & de Pourbaix, 2019). Obesity, diet and physical inactivity have
been identified to cause human cancers at a rate of at least 35%. Given that 30 % of
cancers occur due to uncontrollable factors, reducing the risks that can be controlled, for
example diet, physical activity, and obesity (Miron, 2018) provide preventable actions.
Hagemann suggests there is need for evidence that women with IDD who qualify for
bariatric surgery or pharmacologic treatments do receive these treatment options like
other women without IDD (Hagemann, 2017). Women with IDD have a right to equitable
treatment of all arrays of treatment from a person-centered approach that address all
individual specific variables.
Although diet and nutrition have been of interest in the medical professions as
early as 1800s in regard to the ability to reduce cancer risk, this information remains
uncertain and not implemented equitably for women with IDD in regard to CC
prevention (Campbell, 2017). Consuming whole food plant-based diet (WFPB) offers the
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most nutritional value in cancer reduction (Campbell & Campbell, 2016) and the
implementation of WFPB eating is not well adapted for this population. While Zam &
Khadour (2017) noted that high fat, high calories added to disease risk, and while Del
Cornò et al. (2017) added that consumption of red meats combined with processed foods
increased cancer risks, this information has yet to diffuse for this population. Equipping
women with this information could lead them to become allies in reducing heath
disparities and in reaching more favorable outcomes from reproductive cancers, including
CC, Other information that can help is health and wellness programs that include
accessible physical activity according to Davies et al. (2011), as it lends itself to better
outcomes for cancer reduction. Other contributing factors to risk are smoking, obesity,
lack of physical activity and large alcohol consumption. Such information must be
included in the health discussions with women with IDD in a culturally competent and
person-centered manner for real transformation to occur equitably for this population.
Health and wellness matters, as it encompasses many dimensions that affect each
other in ways that create a sense of well-being (Hewitt & Nye-Lengerman, 2019). In
addition to physical exercise and good nutrition, the aspect of environmental barriers
leaves many not included in their community, and PWD face environmental and
community barriers at higher rates than those with no disabilities, for example, nonaccessible neighborhoods for safe walking, or availability of fresh foods. Health
disparities due to fewer physicians taking the most common form of insurance for this
population means people with IDD have less preventative care. In addition, provider-
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patient interactions do not get to culturally competent care in most cases, mostly because
physicians are not trained on how to work with this population.
Summary and Conclusions
Disparities in health occur among women with disabilities, more so for women
with an IDD and more complex disabilities. Further, CC screening quality/rates lag
HealthyPeople 2020 goals. This literature review identified a need for cultural and health
competencies that are needed for this group. There is a need for examining early
detection as well as an examination of actions resulting after such studies (Brown et al.,
2016). It was clear that knowledge for women with IDD, their caregivers/ families and
DSPs is lacking. It was also clear that healthcare professionals are still not well equipped
to handle the challenges of this population.
Disparities in health do exist for women with IDD, and they are receiving health
services at rates lower than women without disabilities and lower than women with other
disabilities. Administrative data is still limited in identifying women with disabilities,
making it hard for epidemiological studies that identify types of disparities for this
population. There is still a gap in professionals that are well trained on disability issues
for the best population-based public health strategies. It was very clear women with
disabilities are receiving CC screening at rates lower than for women with other
disabilities as well as for women with no disabilities. According to Parish et al. (2018),
PWD with cancer were admitted to hospital more frequently than those without IDD
from an Australian study finding where women with IDD were hospitalized more than
men with IDD. Women with neurological conditions and mental disorders received less
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radiation therapy and breast conservative surgeries than their peers with these disabilities.
Women with ID were more likely to die from cancer. According to Parish et al.,
discharges of women with IDD were associated with higher rates of uterine cancer and
lower incidences of CC from the 2010 Healthcare and Utilization Project Nationwide
Inpatient Sample representing hospital data.
What was very limited, and not known, despite all the evidence noted above, was
the relationship between CC and women with disability types in KY as evidenced in
clinical data. There were no population-based studies that compared CC, other
reproductive cancers in relation to women with and without disabilities and the general
population through the use of inpatient and outpatient discharge data. Given that 35% of
the KY population has some disability, this is a huge gap in the literature.
This study will examine the IHD and OSD data to determine the relationship
between CC and women with and without disabilities in comparison with other
reproductive cancers to examine the influence of the predictors of disability status, age,
payer type, zip code, and length of hospital stay. This study will also examine the
characteristics of the women receiving the treatment based on after their inpatient or
outpatient treatment discharges for any structural or intermediary determinants of health
(Solar, 2010).
This chapter provided a review of the literature pertaining to the relationship
between CC and women with IDD and disability as a whole, and more specifically, to the
determinants of health and disparities experienced in CC screening and prevention efforts
of this population. There have been many innovative health and wellness strategies, and
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preventative strategies in place in KY. The SDOH framework was shown to be ideal for
digging deeper into the complexities pertaining to this population and was chosen as a
more ideal framework. The chapter concluded with an introduction to the types and
availability of administrative data available to the researcher. This data was used to
explore the relationship between CC and women with and without IDD and disability as
a whole and the predictive determinants of health in KY from a population-based
prevalence as evidenced by hospital discharges and also to examine the characteristics
found among these women. The purpose of this study as previously stated was to
understand the influence of the determinants of health in CC for women with disability
that include IDD in KY. The next chapter—Methodology—reviews these sources of data
in more detail and describes how the researcher intends to use these sources for analysis.
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Chapter 3: Research Method
Introductions
This study examined the relationship between CC and women living in KY with
and without a disability, including women with IDD. This chapter addresses the research
design and rationale, the methodology, threats to validity, and ends with a summary. Use
of the term women with disabilities for the purpose of this study and chapter, refers to
different types of disabilities, including IDD.
In order to examine the relationship mentioned above in a methodology that
aligns with the SDOH, CC was examined together with other reproductive cancers—
cancers of the cervix, breast, uterus, ovary, and other female genitals—among KY
women with and without a disability. I considered it important to carry out meaningful
work by using a sample more representative of what was occurring in relation to SDOH
as part of the methodology. The study design offered a valid relationship from a
population-based point of view, as evidenced by actual hospital discharges. The
characteristics of these discharged women after they received treatment of the
reproductive cancers was examined. Such characteristics as patient status, payer type,
age, zip code or county of residence, disability status, and length of hospital stay were of
interest. Isolating patient diagnoses and identifying women with disabilities discharged
from reproductive treatment as an independent variable was of great importance. The
corresponding demographic data revealed specifics of the population being studied, KY
women discharged from a reproductive cancer that included CC and a pre-existing
diagnosis of disability. I intended this data to be used to gain insights into the challenges
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facing the population of study to gain further insight into more effective prevention
efforts targeted specifically for this population.
The following research questions guided the study from the IHD data:
RQ1: Is there a statistically significant relationship between the inpatient
discharge status of a woman (with or without disability), payer type, age, county of
residence, and diagnosis of reproductive cancer?
H01: There is no statistically significant relationship between inpatient discharge
status of woman (with or without disability), payer type, age, county of residence,
and diagnosis of reproductive cancer.
Ha2: There is a statistically significant relationship between inpatient discharge of
woman (with or without disability), payer type, age, county of residence, and
diagnosis of reproductive cancer.
A similar research question guided the data regarding women discharged from
outpatient care.
RQ2: Is there a statistically significant relationship between outpatient service
discharge status of woman (with or without disability), age, county of residence, and
diagnosis of reproductive cancer?
H02: There is no statistically significant relationship between outpatient service
discharge status of woman (with or without disability), age, county of residence,
and diagnosis of reproductive cancer.
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Ha2: There is a statistically significant relationship between outpatient service
discharge status of woman (with or without disability), age, county of residence,
and diagnosis of reproductive cancer.
Variables
Independent variables (IV) for this study included women with and without
disability discharged from reproductive cancer treatment. Women with IDD were
proposed to have been identified using the ICD-10-CM (CDC, 2020f), as noted in Table
3. Other IVs include such concomitant characteristic information as, payer type, age, and
county of residence within the geographic boundaries of KY.
The dependent variable (DV) for this study was women discharged from inpatient
or outpatient hospitals/health care facilities with a diagnosis of one of the five
reproductive cancers.
Inpatient hospitalization or outpatient services care for five reproductive
cancers—cancer of the cervix, breast, uterus, ovary, or other female genitals—as
identified in the ICD-10-CM procedures and diagnoses codes was used for this research. I
examined the relationship between women with and without disabilities discharged from
reproductive cancer treatment with regard to age, payer type, county of residence and
reproductive cancer status.
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Table 3
Classification of Intellectual and Developmental Disabilities
Intellectual and Developmental disabilities
Mild Mental Retardation

ICD-10-CM code
F-70

Moderate Mental Retardation

F-71

Severe Mental Retardation

F-72

Profound Mental Retardation

F-73

Unspecified Mental Retardation

R42.82

Fragile X Syndrome

Q99.2

Prader-Willi Syndrome

Q87.11

Down Syndrome

Q90.9

Rett Syndrome

F84.2

Lesch Nyhan

E79.1

Cri du Chat

Q93.4

Autistic Disorder

F84.0

Childhood Disintegrative Disorder

F84.3

Other Specified PDDs

Q51.28

Unspecified PDD

F60.9

Tuberous Sclerosis

Q85.1

Fetal Alcohol Syndrome

Q86.0

Athetoid cerebral palsy

G80.3

Spastic diplegic cerebral palsy

G80.1

Spastic hemiplegic cerebral palsy

G80.2

Spastic quadriplegic cerebral palsy

G80.0

CP Monoplegic

G83.30

Other CP

G80.8

Infantile CP

G80.4
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Research Design and Rationale
The research design used in this study was correlational in a quantitative method
using secondary data. This approach was necessary to understand the relationship
between CC and women with a disability as well as identifying the relationship between
the variables that exist for women with and without a disability discharged for the same
five reproductive cancer treatments (see Parish et al., 2018). There were no constraints
regarding time for data collection, and the cost to download each dataset for research
purposes was $10, payable to KCHF. The objective of understanding the relationship
between the variables was imminent. Given there are 43 options for patient status, and
that any woman could fall into any such status, the information was used as-is (See
Appendix A).
This study used secondary data not only because it was readily available, but
because this data was a great representation of what is occurring in KY. This data also
offered opportunities for analysis that would be hard to capture from primary sources
while providing insight into the health services for women in KY. Further, secondary
data includes unique characteristics and features, allowing a researcher the ability to
disaggregate during the statistical analysis (Evans, Grella, Murphy & Yih-Ing Hser,
2010). While acquiring data was expedited by the fact that it was readily available, I took
care to ensure data cleaning and preparation was conducted appropriately. For these
reasons, it was a logical choice for the researcher to use the KCHFS data to answer the
research questions.
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Population Sampling Procedures from Secondary Data
The target population for this study was all women discharged from inpatient
hospitalizations and outpatient services. Women with and without disabilities were also
drawn for regression to examine what if any disparities existed between the two groups of
women. This study exclusively examined those women discharged after the treatment of
one of the five female reproductive cancers – cancer of the breast, uterus, cervix, ovaries,
or other genital organs. These reproductive cancers were used in the analysis. The women
with IDD could not be identified as the coding described in the ICD-10-CM as
described by Table 3 was not used This study used all women discharged with CC as part
of the reproductive cancers and examined associations or differences between those with
and without disabilities. Data was available from 2014 to 2018, which made it possible to
find an appropriate sample for analysis. However, data from 2014 was dropped because
the ICD-10-CM codes were implemented in 2015. Using 2014 would not have yielded
results based on a standard method. The desired sample size was calculated using the
estimation of sample size formula based on the event per variable (EPV; Bujang, Sa’aat,
Sidik, & Joo, 2018).
I considered using the individual woman as the unit of analysis. However, to do
so would compromise anonymity and privacy, hence the choice was made to examine the
discharge status of women with any of the five reproductive cancers as the unit of
analysis. Using the individual woman also would have required additional administrative
data, which I might not have been able to obtain given the vulnerable nature of the
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population being studied. As stated earlier, according to CDC (2020b), the population in
KY comprised of approximately 677,681 women living with a disability.
Power Analysis
I compared two groups of women from KY, those with and those without a
disability, discharged from an inpatient hospital or outpatient health services for
treatment related to a reproductive cancer. It was expected that discharged women
without a disability would be more than double the number of those discharged women
with a disability. It was also possible that the same woman could have been discharged
more than once in the same year or over several years.
To increase the sample size, to have a large enough population for practical
significance, CC was observed together with other reproductive cancers (see Daniel &
Cross, 2013). Furthermore, the population for this study was for the years between 2015 2018. Effect size can be explained as the magnitude of the result, either in ratio or in the
difference found in the population. A good sample size was needed to determine the
effect size. Given this information and expecting a higher number of discharged women
without disabilities, it was prudent to have as large of a sample size as possible to be
closer to the population value (see Daniel & Cross, 2013).
The formula n = 100 + xi was used to estimate sample size based on event per
variable (EPV; Bujang et al., 2018). In this formula, i represents the number of
independent variables while x is an integer. The recommended rule of thumb is to use 50
as the integer: n = 100 + 50 (i) for observational studies (2018). In this case, n = 100 + 50
(four independent variables) = 300. For OSD, using the same formula with three
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independent variables, 250 women with disabilities would be needed for a good sample
size. It was not possible to merge the IHD and OSD data as described previously as there
was no unique identifier with which to do so. As such, I carried out every due diligence
and was able to identify 304 discharges of women with disabilities in the IHD and 280
women with disabilities in the OSD data, which was important for validity of results (see
Daniel & Cross, 2013).
Secondary Data Access and Procedure
The KCHFS had a systemic process in place for retrieving operational data. The
KCHFS encouraged use of their data for research only after it had been decoded. I signed
an agreement for ownership and protection of the data. Each data set cost $10 as it was
being used for academic purposes. The data was then downloaded from the KCHFS
website in a secure manner, then cleaned and used for analysis. The integrity of the data
was evaluated prior to analysis. The KCHFS provided a codebook for each data set, and
the person responsible for the data was available for questions and more specific details.
This was helpful in aligning the data to the research questions to fit the anticipated
statistical test of MLR analysis.
The MLR is used to predict the dependent variable, given one or more
independent variables. The assumptions of MLR include that the dependent variable
should be measured as a nominal value, although it could also be of ordinal value, with
the recommendation of using ordinal regression if that was the case (Laerd Statistics,
2018c). Other assumptions include that one or more independent variable was in use and
could be of nominal, ordinal or continuous values, that observations are independent with
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an exhaustive and mutually exclusive dependent variables category and that the
independent variables could not be highly correlated causing multicollinearity. A linear
relationship between independent and dependent variables was another assumption as
was the fact that there should be no outliers according to Laerd Statistics. (2018c). This
study was utilizing a dependent variable at the nominal value with five categories (five
reproductive cancers) and using several social determinant variables as predictors to the
dependent variable.
Operationalization of the Variables
The data collected by KY Hospitals was representative of the population in KY
for the years of 2015 to 2018. The validity and reliability of the data is verified as it is
submitted. KCHFS checks for completeness and presence of required fields, duplicate
records, the validity of submissions, and timeliness. Records with errors are returned to
hospitals and facilities for resubmission upon correction. (KCHFS, 2017a) Table I
contains the operationalization and coding of the variables of interest for this study and
contains those ICD-10-CM codes that will be used to identify women with IDD and as
adopted from Parish et al. (2018). The ICD-10-CM codes were updated to reflect current
codes.
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Table 4
Coding and Operationalization of Study Variables
Variable Name
Diagnosis of
Reproductive
Cancer

Variable Type
Dependent

Operationalization
Nominal

Discharge status of
woman

Independent

Nominal

Age

Independent

Categorical

County of residence

Independent

Ordinal

Patient Status

Independent

Scale

Insurance Payer

Independent

Categorical

Coding/Values
Cancer of uterusC55
Cancer of breast Range: D05.02 –
D07.1
Cancer of cervix C53.9
Cancer of ovary C79.60
Other female
genitals- D07.3,
C57,
Woman with IDD
0 = No, 1 = Yes
Age Group
Range 6 -16
Federal
Information
Processing
Standard Code
Range 0 – 95 (See
Appendix A)
PayerGroup
Range 1-5
1-Medicare
2-Medicaid
3-Commercial
4-Self-Pay&
Charity
5- Other

Data Analysis
Data was analyzed using Statistical Package for the Social Sciences (SPSS)
version 23.0. The MLR test was used for analysis. The dependent variable is a nominal
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variable with four independent variables that are continuous, ordinal and nominal. The
retrieved data was examined for the independence of observations while the dependent
variable was examined to ensure it was mutually exclusive and that categories were
exhaustive. During the analysis, the test for multicollinearity was added and a linear
relationship was established between the continuous independent variable and the
dependent variable’s logit transformation. Outliers and influential high points were
minimized (Laerd Statistics, 2018c).
This study’s research questions were revised from Chapter 1 to reflect the
literature review discoveries of what was already known and what was not known as
described earlier. The research questions were also revised with the understanding that
CC is one of the reproductive cancers. By including other reproductive cancers, it was
possible to increase the sample as well as the associations in the variables of interest. The
research questions were therefore as follows:
RQ1: Is there a statistically significant relationship between IHD status of woman
(with or without disability), payer type, age, county of residence, and diagnosis of a CC?
H01: There is no statistically significant relationship between IHD status of
woman (with or without disability), payer type, age, county of residence, and
diagnosis of a CC.
Ha1: There is a statistically significant relationship between IHD status of woman
(with or without disability), payer type, age, county of residence , and diagnosis
of a CC.
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RQ2: Is there a statistically significant relationship between OSD status of woman
(with or without disability), age, county of residence, and diagnosis of a CC?
H02: There is no statistically significant relationship between OSD status of
woman (with or without disability), age, county of residence, and diagnosis of a
CC.
Ha2: There is a statistically significant relationship between OSD status of woman
(with or without disability), age, county of residence, and diagnosis of a CC.
Merging and appending was necessary, although the researcher was open to the
thought of merging should the inpatient and outpatient data sets have benefitted from
merging. Merging files occurs to allow for two data sets to be combined for analysis of
variables that may not be present in either data set unless they are combined (Bates
College, 2019). Merging was not possible; hence the research questions were not revised
to be one question and the inpatient and outpatient status were not included as an
independent variable. Merging files would have only occurred if there was a way to link
both inpatient and outpatient data using a single identifier and in so doing, capturing all
the women treated with the five reproductive cancers both at the inpatient and outpatient
hospitals/health centers. This would have given the best of two datasets/files. In order to
merge two files, there should be a plan to examine if there is a single identifier common
in both and to ensure that that identifier is either numeric (e.g. ID number) or a string
variable. The common variable would need to have the same name or value (Princeton
University, 2011).
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The datasets had the age variable already converted from a continuous to a
categorical variable. Patient status, on the other hand, could not be converted into a
categorical variable and it was used to identify women with disabilities based on the
services they were discharged to. There was some missing data, however, since a
multiple regression method of analysis was being used, this helped with ensuring missing
data did not affect the validity of results. Multinomial Regression helped with
compounding and bias challenges.
Appropriate descriptive statistics were used. The median household income for
the patient’s county of residence were identified as well as the mean of hospital stay in
days it took for the women to be discharged from inpatient hospital services of
reproductive cancer treatment. The frequency of the insurance payer type was calculated
as well as the age of the women. Inferential statistics were used to help generalize the KY
population by use of the study sample that is a good representation of the general
population. It was important that this study ensured the sample extraction strategies
adhered to the reduction of error and bias so that results could be valid. Inferential
statistics were helpful to estimate parameters and in the testing of the hypothesis (Laerd
Statistics, 2018b). Inferential statistics compared data with theories and ideas to see how
well they faired, or if there is a statistical significance (Kamrin, 2010).
The Odds Ratios (OR) were used in the description of the results of the analysis.
The Confidence ratios were useful in measuring the uncertainty due to the use of the
sample and the Confidence Intervals was set at the 95% estimate range of where values
fell for the entire population and if anything deviated from that, it was significant
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(Marshall & Jonker, 2010). When the statistical significance was clearly stated, and the
null hypothesis accepted or rejected, the conclusion was made.
Reliability and Validity
The inpatient and outpatient datasets were not “ready for analysis” and there was
missing data or data that was incomplete, of poor quality, or biased. However, this study
did not foresee many challenges with external and internal validity issues because data
was checked and corrected as it was collected to minimize errors through quality data
measures as certified by KCHFS. Missing data challenges have been mentioned earlier.
However, multiple regression was a good analysis to deal with missing data. Selection
bias was not an external validity issue; however, the study chose to use the populationbased dataset to make generalizations possible because the sample drawn was a
representation of the general population. This study used inpatient and outpatient
discharges as the unit of analysis, instead of the patient themselves and the threat here
was to explain the results from a patient focus. However, care was taken to explain the
results from the discharge unit of analysis.
Ethical Considerations
There are typically fewer risks and ethical concerns when using secondary data
because it is pre-existing, and although the population of interest is a vulnerable one,
anonymity and confidentiality was already assured because the data included no
identifiable information and informed consent was not necessary for ethical
considerations. However, the researcher sought Walden University’s Institutional Review
Board (IRB) approval and permission was granted with IRB approval number 04-28-20-
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0658410. Permission was also sought from KCHFS as well as from the University of
KY’s CCTS for the use of their data for this study prior to data retrieval. Data retrieved
from KCHFS and CCTS was maintained in a password-protected computer and stored
appropriately per Walden procedures. There were no conflicts of interest or incentives in
relation to the study.
Summary
This chapter stated the purpose of the study, especially after the insights gained
from the literature review, necessitating a revision of the research questions. Another
thorough review of methodology necessitated the use of more appropriate variables that
would answer the unknown. The research then turned to examine the prevalence of five
reproductive cancers with an emphasis with cervical cancer among women with and
without disabilities, as well as identifying the characteristics of these discharged women
as part of the research design and rationale. This chapter also covered the population,
sampling procedure, operationalization of variables, the data analysis, threats to validity,
and ethical considerations. Once the proposal for this study was approved, IRB approval
was obtained. With these two approvals, the researcher downloaded the data and prepared
it for analysis, the process and the results of which are detailed in Chapter 4
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Chapter 4: Results
Introduction
The purpose of this observational and cross-sectional quantitative research study
was to explore the relationship between CC and women with IDD in KY as evidenced by
reproductive cancer discharge data from inpatient and outpatient treatment centers. This
study is important in that women with IDD are a vulnerable population that typically
require lifelong support and a dependence on public funding either through Medicare or
Medicaid (see Knox, 2008; Parish et al., 2018). In public health, there is scrutiny for
more innovative, efficient healthcare purchasing processes for people with IDD,
including a reduction of CC incidences among women with IDD (Anthes, 2018; Drum et
al., 2009).
Information used for this study was representative of the population as it was
based on actual discharge data from both the IHD and OSD databases as reported to the
KCHFS. The data was an excellent source of information of what occurred in KY during
the 4-year period 2015 to 2018.
Two research questions guided this study as follows:
RQ1: Is there a statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer?
H01: There is no statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer.
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Ha2: There is a statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer.
A similar research question was used to capture those women discharged from
outpatient care.
RQ2: Is there a statistically significant relationship between outpatient hospital
discharge status of woman, age, county of residence, and diagnosis of reproductive
cancer?
H02: There is no statistically significant relationship between outpatient discharge
status of woman, age, county of residence, and diagnosis of reproductive cancer.
Ha2: There is a statistically significant relationship between outpatient hospital
discharge of woman, age, county of residence, and diagnosis of reproductive
cancer.
This chapter describes the protocol for data collection and analysis. It concludes
with a presentation of the results of the data investigation and a summary of the findings.
Data Collection
Secondary data from the IHD and OSD as reported to the KCHFS was
downloaded for the 4-year period, 2015 to 2018. The year 2014 was dropped and not
used for analysis due to a different coding system, while data for 2019 was not yet
available. For the purposes of this research, data from the KCHFS was hard to follow and
analyze, however, the University of KY’s Center for Clinical and Translational Science
(CCTS) had the same data available for researchers. CCTS’s Biomedical Informatics
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staff are trained on data, with a specialty of ensuring validity and translating data for
research. With IRB preapproval, CCTS staff were able to extract the same information as
contained in the KCHFS databases in variables suitable for research, and I downloaded
this secondary data in May 2020.
Several subsequent, revision downloads were needed to ensure appropriate
capture of all variables and with additional relevant data regarding women diagnosed
with one of the five reproductive cancers of interest. It should be noted the ICD-10-CM
was implemented in October 2015. As such, using only ICD-10-CM codes for inclusion
would fail to have captured data for January through September 2015. Data was provided
in a way that identified the dependent variable (diagnosis of reproductive cancer) and the
independent variables identified in this study’s research questions (i.e., discharge status
of woman from the patient status and diagnosis, payer type, age, county of residence,
etc.). CCTS required a signed contract, detailing provisions for the public use of this data
within their set boundaries. I am grateful for the CCTS data service, which is supported
by the National Institutes of Health’s National Center for Advancing Translational
Sciences (grant #UL1TR001998).
Included in the secondary data were data characteristics for women between the
age of 21 and 74. Variables of interest for this study were diagnosis of cancer of the
uterus, breast, cervix, ovary, and of other female genitals; discharge status; age; county;
length of hospital stay; patient status; and, insurance payer. It was important to use the
county information in a meaningful way, and the data presented KY’s Federal
Information Processing Standard (FIPS) codes for each of the 120 counties (see
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Appendix C). Upon further review, it was noted that each county had been assigned a
health factor based on four factors: health behaviors, clinical care, social and economic
factors, and physical environment. This ranking was done by the County Health Rankings
& Roadmaps program, a collaborative effort between the University of Wisconsin
Population Health Institute and the Robert Wood Johnson Foundation (County Health
Ranking & Roadmaps, 2020). The collaboration is backed by a strong belief that health
equity is for all people, regardless of race, ethnicity, gender, income, location, or other
factors. The health factor rankings uniquely measure the health of most all counties in the
U.S. for action and community learning.
Each county in KY was ranked on a scale from 1 to 120 with 1 being the highest
rank and 120 the lowest. This information was used to represent the counties of residence
in the analysis. Figure 5 displays the counties and their rankings, although it is important
to note that ranking masks the differences within each county as well as differences
between counties. The spread of the ranking is represented by scale to the right of the
figure, and the graph represents the size of gap between counties in the ranking. Shadings
display the quantiles used in the map and are similar to the social determinants map from
Chapter 2. Appendix B features a map with the regions of Kentucky by household
income.
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Figure 5. Map of Kentucky counties ranked by Health Factor scores. The scale at right
shows the quartile distribution of counties by Health Factor rank. Retrieved from
https://www.countyhealthrankings.org/reports/state-reports/2020-kentucky-report

Descriptive statistics from the data analysis are provided in the tables that follow.
Inferential statistics are also provided after conducting the MLR model.
None of the ICD-10-CM codes yielded any results that could readily identify
women with IDD. Women with disabilities were identified using other characteristics,
such as the type of service to which they were discharged, insurance payer,
Medicare/Medicaid, Severity Diagnosis Related Groups and descriptions. It had been
anticipated that women with IDD would be invisible in the data. Since it was not possible
to distinguish women with IDD among those with other disabilities, the discharge status
of woman was changed to reflect women with and without a disability.
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Data provided by CCTS’s Biomedical Informatics team was further cleaned to
reflect only data from KY, thereby excluding IHD and OSD data from Ohio, Indiana,
Pennsylvania, Massachusetts, Colorado, New York, Michigan, Tennessee, Illinois,
Georgia, West Virginia, Florida, Mississippi and some international destinations. The
number of women visiting KY for oncology services was a testament of the quality of
such services provided in KY.
Discharges of women from KY were identified by zip code and FIPS code. For
the IHD, there were 1,837 women without a disability and 304 women with a disability,
of which 1,947 women were White, 175 women were African American, 45 were
Hispanic or Latino, and 7 identified as Asian. The data represented other, minor
races/ethnic demographics as well. For the OSD, there were far more women without a
disability—30,936—and 280 women with a disability. Of these, 28,336 were White,
2,260 women were Black or African American, 2,529 were Hispanic or Latino, and 98
identified as Asian.
Descriptive Statistics
Table 5 shows the IHD and OSD data and provides information on the highest
frequency of cases ranked by the health factor assigned to each county, which was further
categorized into groups. The health factor group with the highest inpatient hospital
discharges was Group 10 (Pendleton, Jefferson, Garrard, Green, Trimble) with 437
(20.4%) discharges, located in the Urban Triangle. Group 5 (Bullitt, Hardin, Calloway,
Kenton, and Franklin) carried 9.6% of the discharges (206) and, in general, there were
more discharges to the Urban Triangle.
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A review of OSD data revealed the highest health factor group was Group 10
(Pendleton, Jefferson, Garrard, Green, Trimble) with 6,813 (21.8%) discharges followed
by Group 2 (Spencer, Boyle, Hancock, Daviess, Fayette) with 3,448 (11%) discharges.
Group 5 (Bullitt, Hardin, Calloway, Kenton, Franklin) had the third highest discharges
with 2,773 (8.9%).
The social determinants of health by KY quantile figure in Chapter 2 offered a
map that was used to rank the information analyzed for the counties found to have the
highest number of discharges. From Table 5, the counties with the highest inpatient
hospital discharges included those from three third tier counties and two second tier
counties (accounting for 20.4% of discharges) followed by two second tier counties and
three top tier counties (9.6% of discharges). From the OSD data, the highest outpatient
hospital discharges came from three third tier and two second tier counties (accounting
for 21.8% of discharges) followed by five top tier counties (11% of discharges), and two
second tier and three top tier counties (8.9% of discharges).
Table 6 shows that women with disabilities were discharged from inpatient care
highest among the 55-59 age group (n = 44), followed by ages 70-74 and 45-49 (n = 39)
with the fewest discharges noted for the 21-25 age group (n = 2). For women without
disabilities, discharges from IHD were highest at 238 for women in the 50-54 age group
followed by 234 discharges for women in the 55-59 age group. Among inpatient hospital
discharges, women with disabilities were discharged at a higher number at a later age
than for women without disabilities.
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Table 5
Inpatient Hospital Discharges (IHD), Outpatient Hospital Discharges (OSD) Data By
County, Health Factor, and Region
Counties
in KY
IHD
Pendleton,
Jefferson,
Garrard,
Green, Trimble

Health Factor

No. of Cases
(n) (%)

Quantile

Region

46-50

437 (20.4)

3 * Third Tiers
and 2 * Second
Tiers

4 Urban
Triangle and 1
South Central
Kentucky

Bullitt, Hardin,
Calloway,
Kenton,
Franklin

21-25

206 (9.6)

2* second tiers
and 3 * Top
Tiers

4 Urban
Triangle and 1
Western KY

Spencer,
Boyle, Fayette,
Hancock,
Daviess

6-10

184 (8.6)

5 Top Tiers

3 Urban
Triangle and 2
Western KY

46-50

6,813 (21.8)

3 * Third Tiers
and 2 * Second
Tiers

4 Urban
Triangle and 1
South Central
KY

6-10

3,448 (11)

5 Top Tiers

3 Urban
Triangle and 2
Western KY

OSD
Pendleton,
Jefferson,
Garrard,
Green, Trimble
Spencer,
Boyle,
Hancock,
Daviess,
Fayette

Bullitt, Hardin,
21-25
2,773 (8.9)
2* second tiers 1 of each
Calloway,
and 3 * Top
Kenton,
Tiers
Franklin
Note.
i) Each county’s health factor ranking appears in Appendix C.
ii) The Kentucky quantiles used in Chapter 2 are reflected under “quantiles.”
iii) A map of Kentucky regions appears in Appendix B.
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Table 6
Age Distribution of Inpatient and Outpatient Hospital Discharges

Years of Age

21-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
Total

Inpatient
Discharges of
Women Without
Disability (n)
17
86
97
164
195
212
238
234
208
202
184
1,837

Inpatient
Discharges of
Women with
Disability (n)
2
12
11
26
24
39
35
44
36
36
39
304

Outpatient
Discharges of
Women Without
Disability (n)
554
1,318
1,641
2,120
2,802
3,361
3,744
4,274
4,358
3,971
2,800
30,943

Outpatient
Discharges of
Women with
Disability (n)
5
9
6
17
23
35
47
35
41
32
30
280

OSD data shows that women without disabilities had the greatest number of
discharges at ages 60-64 (4,358), followed by women in the 55-59 age group (4,274
discharges). Women with disabilities had the greatest number of discharges at ages 50-54
(47), followed by 41 discharges at ages 60-64, with the least number of discharges at ages
21-24 (5). Based upon the highest rates of discharge by age, women with disabilities were
more likely to be discharged at a younger age than women without disabilities (ages 5054 versus ages 60-64 from outpatient services.
Table 7 shows the race and insurance payer characteristics for women with IDD
and without based upon the IHD, OSD data. The table shows there were 27 discharges
linked to Black, African American women, and 274 discharges linked to White women
from the IHD for women with disabilities. Comparing this to the OSD data, 7 discharges
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were linked to Black, African American women while 265 were linked to White women.
The numbers were higher for women without disabilities. The highest source of funding
from the IHD data for women with disabilities was Medicare (116) followed by Medicaid
(104) with a similar pattern for those without disabilities (695 and 603 respectively). This
pattern was the same for the OSD; in total, public insurance was utilized more, despite
commercial insurance being high for women with disabilities (127) as well as for women
without disabilities (12,970). The mean age group was ages 40-44 years old for the IHD
and 50-54 years old for the OSD. The mean hospital stay was 5 days. The average total
cost for the IHD for all women was at $ 46,841.88 while that of the OSD was six times
less at $ 7,678.23.
Table 8 compares the IHD and OSD data for women with disabilities and without
based upon cancer diagnoses. More women with disabilities received outpatient breast
cancer treatment (181) than inpatient treatment (58). The data also shows more women
with disabilities received inpatient services than outpatient services (130 versus 53) for
cancer of the cervix. CC was the highest type of inpatient reproductive cancer among
women with disabilities (130), followed by cancer of the uterus (68), and ovarian cancer
(13), which had the least number of discharges. Among outpatient discharges, women
with disabilities received more services for cancer of the breast (181), followed by cancer
of the cervix (53). Cancer of the ovary had the least number of discharges (3).
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Table 7
IHD and OSD Race and Insurance Payer Data for Women with and Without Disabilities
IHD

OSD

Women with
Disability
(N= 304)

Women Without
Disability
(n=1,837)

Women with
Disability
(n=280)

Race
American
Indian

1

2

0

11

Asian

1

6

5

293

27

148

7

2,253

274

1,672

265

28,071

0

36

2

527

Insurance
Payer
Medicare

116 (38)

695(37)

86 (31)

9,136 (30)

Medicaid

104 (34)

603(33)

59 (21)

8,053(26)

Commercial

76 (25)

478 (26)

127 (45)

12,970(42)

Selfpay/Charity

6

38

3

4,09

Other

2

23

5

375

Black or
African
American
White
Hispanic

Women
Without
Disability
(n=30,936)
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Table 8
Inpatient Hospital Discharges (IHD), Outpatient Hospital Discharges (OSD) for Women
with and Without Disabilities by Type of Cancer

Type of Cancer

IHD
Women with
Women
Disability
Without
(n = 304) (%)
Disability
(n = 1,837) (%)

OSD
Women with
Women
Disability
Without
(n = 280) (%)
Disability
(n = 30,936)
(%)

Uterus

68 (22)

422 (23)

26 (9)

3,243 (10)

Breast

58 (19)

321 (17)

181 (65)

17,067 (55)

Cervix

130 (43)

817 (44)

53 (19)

8,064 (26)

Ovary

13 (5)

55 (3)

3 (1)

374 (1)

34 (11)

219 (12)

17 (6)

2,146 (7)

Other female
genitals

Just as women with disabilities had higher IHD rates for CC (43%) and cancer of the
uterus (22%), women without disabilities also had the highest number of inpatient discharges for
CC (44%) followed by cancer of the uterus (23%). OSD data shows that women without
disabilities had highest discharges for breast cancer (17,067) followed by CC discharges (8,064)
and the least number of discharges were for cancer of the ovary (374). Women with disabilities
had similar high rates of breast cancer (65%) followed by CC (19%).
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Inferential Statistics
Research Question One
RQ1: Is there a statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer?
H01: There is no statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer.
Ha2: There is a statistically significant relationship between inpatient hospital
discharge status of woman, payer type, age, county of residence, and diagnosis of
reproductive cancer.
Results of Research Question One
MLR was used to test the hypothesis on the relationship between the discharge status of
woman, age, county of residence (categorized into health factor continuous scale),
insurance payer, and the diagnosis of reproductive cancer. The number of women with
disabilities identified in the data was 304, just short of the 400 predicted in Chapter 3.
The hypothesis was tested with four independent variables to maintain the effect size as
calculated in Chapter 3 for power of analysis. The independent variables used were i)
discharge status of woman, ii) county of residence (categorized into a health factor
ranking), iii) age group and iv) insurance Payer. This model was found to be statistically
significant in identifying the relationship between the discharge status of woman, payer
type, age, county of residence and the reproductive cancers as noted in Table 9.

100
Table 9
Model Fitting Information

Model
Intercept
Only
Final

Model Fitting
Criteria
-2 Log
Likelihood

Chi-Square

df

Sig.

4,607.849

--

--

--

4,255.636

352.213

112

.000

Likelihood Ratio Tests

The Nagelkerke results indicated that 16.2 % of the variance in the diagnosis of
reproductive cancer was accounted for by the combination of the independent variables.
From Table 9, the variables added improved the model in a statistically significant
manner as compared to the intercept alone, and as noted, the chi-Square was 352.2. The
p-value was at .000, therefore, the null hypothesis was rejected. There is a statistically
significant relationship between payer type, county of residence (categorized into a health
factor scale), and diagnosis of reproductive cancer.
The likelihood ratio tests in Table 10 shows the independent variables most
significantly related to a diagnosis of reproductive cancer. The discharge status of a
woman (with or without disability) and the age group were not significant observations (p
= .443 and p = .996 respectively). The county to which a woman was discharged to
(categorized in health factors scale) was found to be statistically significant (p =.014) as
well as the insurance payer (MSSOP) at p =.000. It is more likely that a woman with
reproductive cancer was from a specific county and used a certain insurance payer.
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Table 10
Likelihood Ratio Tests for Inpatient Hospital Discharges
Model Fitting Criteria
Likelihood Ratio Tests
-2 Log Likelihood of
Effect
Reduced Model
Chi-Square
Df
Sig.
a
Intercept
4,255.636
.000
0
--.
FIbhealthfactor
4,273.206
17.570
7
.014
Dischargestatus
4,262.503
6.867
7
.443
AGE_GROUP
4,298.479
42.843
70
.996
MSSOP
4,543.251
287.615
28
.000
Note. The chi-square statistic is the difference in -2 log-likelihoods between the final
model and a reduced model. The reduced model is formed by omitting an effect from the
final model. The null hypothesis is that all parameters of that effect are 0.
a. This reduced model is equivalent to the final model because omitting the effect does
not increase the degrees of freedom.

In looking at the parameter estimates output for this model (see appendix D), the
odds of being diagnosed with a reproductive cancer as determined by the county in which
a woman lived was 1.081 as likely for cancer of the uterus, 1.081 for breast cancer, 1.084
for cervical cancer, 1.079 for cancer of the ovary, and 1.089 for other female genitals.
The odds of being diagnosed with a reproductive cancer for women without disabilities
was higher across the board (1.26 for cancer of the uterus, 1.1 for cancer of the breast, 1.3
for CC, and 1.3 for other female genitals), but much higher for cancer of the ovary (8.8).
It was apparent that women on Medicare received more treatment for cancer of the ovary,
while women on Medicaid were 9.6 times as likely to be diagnosed with CC and 6.9
times as likely to be diagnosed with cancer of other female genitals. As to whether a
woman’s status (with or without disability) confounded the relationship of reproductive
cancer, this was found not to be statistically significant.
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Research Question Two
RQ2: Is there a statistically significant relationship between outpatient hospital
discharge status of woman, age, county of residence (ranked into a health factor scale),
and diagnosis of reproductive cancer?
H02: There is no statistically significant relationship between outpatient discharge
status of woman, age, county of residence (ranked into a health factor scale), and
diagnosis of reproductive cancer.
Ha2: There is a statistically significant relationship between outpatient hospital
discharge of woman, age, county of residence (ranked into a health factor scale),
and diagnosis of reproductive cancer.
The hypothesis was tested using MLR to determine the significance of the
relationships between a woman’s discharge status (with or without disability), age,
county of residence, and diagnosis of reproductive cancer of woman. The independent
variables were reduced from 5 independent variables to 3 because only 280 women with
disabilities were identified in the OSD as opposed to the 350 planned for in Chapter 3 for
effect size. Since this study used the SDOH framework, keeping the county of residence
(categorized into a health factor scale), discharge status, and age was more fitting. The p
values less than .05 for any of the independent variables, i.e., discharge status of woman
(distinguishing between woman with or without disability), age (categorized in age
group), and county of residence (ranked into a health factor scale) would point to a
significant association with diagnosis of reproductive cancer. In using this model to
analyze data, approximately 10% of the variance in the diagnosis of a reproductive cancer

103
was accounted for by the combination of the independent variables. The model was found
to be statistically significant in predicting the dependent variable better than using the
intercept-only model. The Chi-Square was large and the p value of less than .05 (at p
=.000), indicated the results were significant in the Model Fitting Information Output.
Results of Research Question Two
Table 11 indicates the Likelihood Ratio Tests Output and shows the changes of
each of the independent variables added. The discharge status of woman (i.e. whether
woman had or did not have a disability) was not found to be a significant contributor to
the relationship of a reproductive cancer (p = .573). The specific individual variables that
demonstrated significant associations with reproductive cancer discharges for the OSD
were the county of residence (categorized into a health factor scale) where the women
were discharged to (p = .000) and age group (p = .000), therefore, the null hypothesis was
rejected. There is a statistically significant relationship between age, county of residence
(ranked into a continuous health factor scale), and diagnosis of reproductive cancer.
The parameter estimates reveal a woman’s discharge status to be significant in the
relationship with reproductive cancers, specifically women without disability, statistically
significantly relating to cancers of the uterus, breast, cervical and ovary all at p = .000
(see appendix E). In comparing reproductive cancer rates for women with or without a
disability, it is more likely a diagnosis belongs to a woman without disabilities. It is more
likely that the discharge from cancer of the uterus, breast, cervix, and ovary was from a
woman without a disability. Women aged 40-44 were 3.6 times as likely to be discharged
from cancer of the uterus; 9.5 times as likely to have cancer of the breast; 2.9 times as
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likely to have CC; 5.1 times as likely to have cancer of the ovary; and, 1.01 times as
likely for cancer of other female genitals. CC diagnosis rates were highest at ages 45-49
than any of the other reproductive cancers.
Table 11
Likelihood Ratio Tests for Outpatient Service Discharges
Model Fitting
Criteria

Likelihood Ratio Tests

-2 Log
Likelihood of
Reduced
ChiEffect
Model
Square
df
Sig.
a
Intercept
22,633.530
.000
0
--.
b
HealthFactors
23,218.085
584.555
15
.000
Dischstatusofwoman
22,646.911
13.381
15
.573
Age_group
25,191.174 2,557.644
150
.000
Note. The chi-square statistic is the difference in -2 log-likelihoods between the final
model and a reduced model. The reduced model is formed by omitting an effect from the
final model. The null hypothesis is that all parameters of that effect are 0.
a. This reduced model is equivalent to the final model because omitting the effect does not
increase the degrees of freedom.
b. Unexpected singularities in the Hessian matrix are encountered. This indicates that
either some predictor variables should be excluded, or some categories should be merged.

Summary
In this chapter, data download and challenges encountered were discussed, as well
as the adjustments made to ensure validity of the sample data. The descriptive and
inferential statistics were calculated to answer the study’s two research questions. MLR
was then used to test the hypothesis.
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For the first research question using IHD, the county of residence (ranked into
health factor scale) as well as the insurance payer were found to be statistically
significant in relation to reproductive cancer. Consequently, for research question two, it
was found that it was more likely that the discharge from cancer of the uterus, breast,
cervix, and ovary was from a woman without a disability. The county of residence
(ranked in the health factor scale) as well as the age of the woman were found to
significantly relate to reproductive cancers. The interpretations of these results, the
limitations of the study, recommendations for future research, as well as the implications
for public health professionals will be discussed in Chapter 5.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This study explored the relationship between CC and women with disability as
evidenced by reproductive cancer discharges from inpatient and outpatient treatment
while comparing population-specific differences from a social determinants of health
framework. The nature of this study was observational, quantitative research based on
women with and without disabilities discharged from reproductive cancer treatment,
including CC. The unit of analysis was the discharge status of the woman (whether they
had or did not have a disability). The study was also a cross-sectional type as it provided
a snapshot of the relationship between CC and women with a disability in KY.
The four independent variables for IHD included the discharge status of woman
(i.e., woman with or without a disability), insurance payer type, age, and county of
resident’s health factor ranking. For OSD, the three independent variables were:
discharge status of woman, age, and county of residence (ranked as health factor scale).
The dependent variable for both the IHD and OSD data sets was the diagnosis of a
reproductive cancer (cancer of the uterus, breast, cervix, ovary and other female genitals).
This study was necessitated by the fact that, despite the many healthcare
interventions available nationwide, CC has persisted, and in KY, CC incidence rates,
which stood at 8.8 per 1,000 people based on 2015 data, eclipsed the healthypeople.gov’s
goal of 7.3 cases per 1,000 (ACS, 2018). Also necessitating this study was the fact that
women with disabilities face more barriers to secondary prevention and health care
access, have more known risk factors, and have greater health disparities than women
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without disabilities and, by extension, are exposed to higher rates of disease and higher
death risks than their peers. As such, this study’s significance lies in filling the gap of
examining the relative prevalence of CC among women with disabilities from both
inpatient and outpatient hospitals and health services discharge data with the noted shift
to the current outpatient cancer treatment. In examining population-specific relationships
between CC and women with disabilities linked to hospital inpatient and outpatient data,
this study’s findings may potentially offer targeted interventions for this population.
Interpretation of the Findings
Inpatient Hospital Discharges
The findings revealed that several factors were associated to a reproductive cancer
(i.e., cancers of the uterus, breast, cervix, ovary, and other female genitals) for both
women with and without disabilities. Past studies showed no association between
reproductive cancers and OSD data, mainly because there had not been a study using
OSD to examine the relationship of reproductive cancer with women with disabilities.
From this study’s literature review, neither has there been such a study conducted that
used both IHD and OSD data, although a study conducted in Australia found cancer
patients had higher admission rates overall, especially among women (see Sullivan &
Hussain, 2008). The findings indicated that more women with disabilities were identified
in the IHD data than the OSD data, which can be attributed to the fact that more patient
variables were captured in the IHD data, affording me the ability to identify more women
with disabilities using variables not present in the OSD data. An earlier study that the
results of my study could not confirm or disconfirm compared women with and without
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disabilities and found those with mental disorders and neurological conditions to have
lower rates of breast conserving surgeries and radiation (Lezzoni et al., 2008).
IHD data findings demonstrate that women without disabilities had the first and
second highest reproductive cancer discharge rates at ages 50-54 and 55-59 respectively.
For the same data set, the highest discharge rates for women with disabilities were among
the 55-59 and 45-49 age groups, which partially confirmed Parish et al.’s (2018) findings
with the difference being that the highest discharge rates among women with disability in
this study was at the same age group that came in second in frequency for women without
disabilities (i.e., 55-59 years).
Findings from the IHD data indicated that 38% of women with disabilities used
Medicare while 34% used Medicaid, confirming Parish et al.’s (2018) findings that a
majority of women with disabilities were on public insurance. It is noteworthy, however,
that both groups of women used public and private insurance at similar rates. In addition,
the mean length of stay for women with a reproductive cancer with or without a disability
was 5 days, although a review of the average found that women with disabilities stayed
longer in a hospital than their counterparts. According to Parish et al., women with
disabilities were from zip codes with lower median incomes. Findings from this current
study indicated that the top five counties to which women were discharged, except for
women with disabilities, came from the region of KY with the highest median income
(the Urban Triangle). This study also found the second highest number of discharges
came from the state’s third highest median income area (South Central KY) while women
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without disabilities had the fifth highest rates of discharge from Eastern KY, the region of
KY with the fourth lowest median incomes.
CC has persisted in KY, and it was the highest type of reproductive cancer,
according to the IHD data, comprising 43% (130) of all reproductive cancers among
women with disabilities and 44% (817) of such cancers among women without
disabilities. CC was the highest reproductive cancer type overall (44.2%, 947 women) in
KY followed by cancer of the uterus (22.9%, 490 women). Of interest, the odds of being
diagnosed with CC for women without disabilities was 1.3 times greater than for women
with disabilities while the odds of being diagnosed with cancer of the ovary for women
without disabilities was 8.8 times higher than that of women with disabilities. The
addition of age-group and discharge status (with or without disability) independent
variables to the model was not significant for the IHD data. However, the independent
variables found to be of most significance were the county in which the woman lived (p =
.014) and insurance payer type (.000).
Contrary to previous research, this study’s findings from the IHD data indicated
that hospitalization for CC was more prevalent than for other types of reproductive
cancers in KY among women both with and without a disability. Cancer of the uterus was
more frequent than breast cancer. In KY, contrary to previous research, public insurance
was utilized at the same rate by women with and without disabilities at a higher rate than
commercial insurances. The study confirmed women with disabilities are likely
diagnosed at a later stage in life and have longer hospital stays. In KY, where a woman
lived, and her insurance were associated more with a reproductive cancer.
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Outpatient Services Discharges
Regarding the OSD data and from this study’s literature review, this study extends
those studies that have come before. The highest number of women with disabilities
receiving outpatient services were between the ages 50-54, while the highest number of
women without disabilities receiving outpatient services were between 60-64. This was a
distinct difference from the results of the IHD data. Women without disabilities were
more likely than women with a disability to have commercial insurance. In addition,
woman with disabilities and a reproductive cancer were most likely discharged from
outpatient services from a Health Factor Group 2 counties (Davies, Fayette, Hancock,
Boyle, or Spencer counties), which is in the Urban Triangle, as were women with uterine
cancer and without a disability. There were no other differences among the highest
frequencies of reproductive cancers. Furthermore, breast cancer had the highest number
of outpatient services (17,248 discharges) among all women in this study, representing
55.3% of all reproductive-cancer related outpatient services.
Many more women received outpatient services than inpatient services with most
of those services occurring among women without disabilities. MLR was found to be a
fitting model for analysis and the county of residence also referred to as the county the
woman was discharged to and age group were the most significant independent variables.
Furthermore, women aged 45-49 were 3.8 times more likely to be diagnosed with CC and
women aged 40-44 were 9.5 times more likely to be diagnosed with breast cancer, which
was also the leading type of cancer, according to the OSD data.
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Conceptual Framework
This study was based on the SDOH. According to the WHO, a comprehensive
framework can:
i) Identify the social determinants of health and the social determinants of
inequities in health;
ii) Show how major determinants relate to each other;
iii) Clarify the mechanisms by which social determinants generate health
inequities;
iv) Provide a framework for evaluating which SDOH are the most important to
address; and,
v) Map specific levels of intervention and policy entry point for action on SDOH
(Solar, 2010, p. 20).
Although the elements of this framework cannot all be included in a single study,
some key areas to consider include the willingness of those in power to guide action that
distributes power benefits to the less advantaged and recognition of the fact that there are
underlying mechanisms that stratify population outcomes, including education,
occupation, race/ethnicity, social class, and gender. These underlying mechanisms that
stratify outcomes are the root causes of health inequities. The SDOH framework is easily
summarized by CDC (2020h) as a consideration of how conditions in the places where
people live, learn, work, and play affect a wide range of health risks and outcomes.
Furthermore, as stated in Chapter 2, people are born, grow, live, work, and age in
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conditions that are shaped by power, distribution of money, and resources at a global,
national, and local level, causing differences in health at each level (see WHO, 2019b).
PWD experience far more challenges than their counterparts in finding a job,
being easily included in the educational mainstream, receiving secondary prevention
services, visiting fitness facilities, obtaining sufficient social-emotional support, and
using health information technology (Healthypeople.gov, 2020). The SDOH framework,
therefore, was used to help identify what mechanisms stratify outcomes for women with
disabilities in relation to CC and reproductive cancers in the constraints of the variables
used for this study. SDOH was used to identify any population-level differences in
women with and without disabilities in the presence of the five reproductive cancers. This
study considered women with disabilities as a subgroup in the population demographic,
and the study used the SDOH framework to explore deeper into the differences among
women with disabilities using a multi-variate analysis to identify the complexities
present.
The SDOH framework emphasizes that those in power have to be willing to guide
actions that change the determinants of health. Women with disabilities were invisible in
data, for both the IHD and OSD databases, and it took considerable time to identify these
women using inputs and characteristics from the Major Diagnostic Category (MDC) and
Medicare Severity Diagnosis Related Groups (MS-DRG) data sets. Using the SDOH
framework, one can interpret women with disabilities’ invisibility in data as a health
disparity. This is an indication that those in power may not have been willing or been
aware of the need to guide action that includes PWD in surveillance systems for better
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health data that can inform program and policy development where issues of health
disparities are critical. Women with disabilities may also not have been empowered,
either through critical reflection or relationships, to ensure shared action in better, more
complete disability health data. Many more women in the OSD database had one of the
reproductive cancers, yet women with disabilities were less (280) than those identified in
the IHD data (304). It is also possible that oncology treatment may not be occurring at the
same rate among women with disabilities in outpatient health centers, affirming findings
from Lezzoni et al. regarding lower rates of breast conserving surgery and radiology
therapy (2008).
According to the SDOH framework, the difference in ages is a form of social
stratification in that women with disabilities were diagnosed at later ages (55-59) than
women without disabilities (50-54 years old) in the IHD data. Again, for the OSD data,
women with disabilities were younger (50-55) than women without a disability (60-64).
This disparity of health exposes women with disabilities to greater cancer-damaging
conditions, especially if the diagnosis is made at a later stage of disease, differentiating
the health outcomes between the two groups of women with respect to vulnerability in
resources and survival. When cancer is diagnosed at a later stage, chances of recovery
and survival may be less. Women with disabilities also had hospital stays longer than the
mean 5 days, indicating disparities in after-hospital discharge patient status or severity of
disease consequences. Given that KY has a median income lower than most states, which
leads more women to utilize public funding, women with disabilities in this study
qualified for both Medicare and Medicare insurance.
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Ovarian cancer rates among women with disabilities was less than that of women
without disabilities. According to SDOH, this disparity may be caused by the fact that at
age 50, fewer women with disabilities are recommended for an ovarian test. Another
disparity was found for CC among both types of women. According to the SDOH, where
the women lived was an underlying cause of the disparities. In addition, the SDOH
framework revealed that the determinants for OSD records were age, insurance type,
county, and cancer type.
Limitations of the Study
Although this study revealed some valuable results, there are some limitations
worth noting. First, this study was based on secondary data from KCHFS, which was not
designed primarily for research and was, therefore, limited in examining CC and other
reproductive cancer due to how cases were captured in IHD and OSD records. For this
reason, the same data was downloaded from CCTS as noted earlier. According to
KCHFS, errors in IHD and OSD input materials are sent back to hospitals and outpatient
facilities for correction. However, data that could have been lost in translation, absent or
miscoded was not verifiable, nor were errors of incomplete information, recall bias, and
noninclusivity of the target population all too common limitations of secondary data. The
second and greatest challenge, however, was that women with disabilities were invisible
in the data. Although the ICD-10-CM codes were implemented in 2015, none of the IDDrelevant codes were used to differentiate women with IDD from other disabilities,
perhaps because health centers may or may not have entered the ICD-10-CM codes when
treating a woman with IDD for a chronic, nondisability condition. It was also not possible
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to identify if women with disabilities lived independently, with family or in group homes
to allow for differences between where they resided in addition to their county of
residence.
Third, I spent considerable time cleaning the data as well as identifying women
with disabilities using other characteristics, such as patient status description (where they
were discharged to). Use of the MDC and the MS-DRG data sets was appropriate and
helped in identifying women with disabilities, yet this process took time. Furthermore,
women with disabilities not identified in the MDC and MS-DRG data sets were not
considered because the method used to identify women with disabilities may or may not
have captured everyone. Outpatient data was even more limited in the MDC and MSDRG data sets, as was patient status, more so because discharge information was limited
in the characteristics included.
The IHD and OSD data was based on the discharge being the unit of analysis as
opposed to a single woman with a unique identifier. The possibility that a single woman
was discharged several times over the 4 years of this study was very likely. According to
Parish et al., (2018) women with disabilities have been documented as having more
repeat hospitalizations and perhaps more outpatient services than their women peers,
which presented as the fourth limitation for this study.
The age limitation for this study was age 21-74 years old and women diagnosed
with a reproductive cancer earlier or later than this age restriction were not considered.
Furthermore, women who may have been deceased before discharge were also not
included. Any or all these limitations could have influenced reproductive cancer case
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outcomes as well as the discharge status of the women, posing a misrepresentation of the
state of KY. While this study acknowledges these limitations, the findings do offer utility
in identifying differences that may allow for target interventions toward health equity for
all women in KY. This study used population-based data, which provided much strength
in the validity of results. Furthermore, the data was high quality and representative of
what has occurred in KY between the years of 2015 to 2018. The data used was not
restricted by sampling bias or selection bias, nor was it restricted to one county in KY, or
from one hospital. To the best of the author’s knowledge, the data was trustworthy as
were the gaps identified.
Recommendations
Future recommendations include research that uses individual women, and not the
discharge, as the unit of analysis, as was the case in this study. A woman could have been
discharged several times in a quarter or year. It is possible that using the woman as the
unit of analysis would inform strategies specific to women in KY. For example, the data
analysis did not allow for investigation into the appropriateness of outpatient or hospital
services, or what the differences in the treatment services were for women with
disabilities as compared to women without disabilities. Furthermore, CC was the highest
type of cancer in the IHD data set, but it was not possible to investigate what, if any, risk
factors were present, nor could the high cases of CC be linked to data that could correlate
minimal screening services or to the challenging, complex barriers for CC screening
among women in KY. Furthermore, longitudinal studies are recommended so as to
provide health outcomes over the long-term and may offer information that helps to
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understand how cultural or social influences, such as information shared among family
and neighbors, for instance, may affect secondary prevention choices.
Future research could use the IHD and OSD data sets and continue the work of
this study by investigating other reproductive cancer types as well as look at trends from
2015 to the current year. This may offer further comparisons of the target population. A
further study could use an external validation of the reproductive cancer rates to arrive to
results closer to the woman as the unit of discharge as much as possible. Such an external
validation could use the KY cancer registry while ensuring the privacy of subjects
through use of a unique identifier. Another means of validation could be tapping into the
databases of private providers of home and community-based services for women with
IDD as recorded by the state, which record any major occurrences in the lives of women
with disabilities for more accurate, individual information while ensuring the privacy of
women subjects is protected.
Implications
This study revealed that, for the IHD data, the county or geographic location of
residence and the insurance payer were associated with reproductive cancer diagnoses.
Women utilizing public funding were more likely to be diagnosed with a reproductive
cancer, and women utilizing Medicaid were 9.6 times as likely to be diagnosed with CC.
For the OSD data, the geographic county of residence and age-group was associated with
diagnosis of a reproductive cancer. Furthermore, women aged 45-49 were 3.8 times as
likely to be diagnosed with CC.
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This study reinforces the need for professionals in health care, as well as public
health leaders, to pay attention to determinants that affect the health factors of each
county in KY in a way that influences change. Furthermore, with increased technology
and interconnectivity between counties, there is the potential to improve environmental
designs and public infrastructure by increasing partnership capacity so as to address
access to secondary screenings toward meaningful health impact among women in KY.
Positive Social Change
Advocacy for increased quality services is needed as part of positive social
change. This advocacy is needed not just for health prevention, but to ensure that services
foster an integrated approach such that, at a community level, women with disabilities are
connected to services that lead to increased adherence to screenings per USPSTF
recommendations. According to the SDOH framework, those in power pay attention to
what they know, and the attention of those in power is informed by what is advocated to
them. Increasing the participation of women with disabilities in all areas of research
would no doubt draw more attention to specificity in the process and in the identification
of more efficacious, healthful strategies for this population. This participation may
include social change with a strong advocacy voice to influence policy makers so as to
influence environmental and physical barriers that allow for accessible CC and breast
screening, as well as increase access to healthcare, issues that can then be well
articulated, and identified in public health agendas and activities in all communities in
KY.
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In regard to an upstream positive social change, from a perspective of a graduate
education in public health, it is extremely important to include disability content that is
both comprehensive and exclusive. Most Master of Public Health graduates go on to
careers in government, or private organizations dealing with the general public, and it
would be of utmost importance to ensure they are ready and well-equipped to identify
gaps in the population for targeted service implementation as well as policies that support
health equity for all. A recent study indicated that only 10 out of 128 Schools and
Programs of Public Health affiliated with the Association of Schools and Programs of
Public Health offered courses in disability in graduate public health curricula (Akakpo,
Lobianco, & Lollar, 2020). Of the 10 institutions, only 3 offered content that was
exclusive and comprehensive in disability content within graduate curricula in Public
health. From that study:
Training professionals in how to identify the magnitude and severity of problems
in the population and then appropriately intervening is the cornerstone of
academic education in public health. Disability as a construct and PWD [persons
with disabilities] as a population facing health inequalities has not yet emerged as
an integral part of public health education and training. (pg. 1510)
Advocacy is needed from PWD, their family members, students, academia
partners, as well as other appropriate stakeholders to include disability content in the
MPH curricula. A well-prepared disability in public health workforce that is competent in
population wide challenges that include targeted interventions for people with disabilities
as a demographic would be a great social change.
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In addition to upstream education, training the workforce already serving in the
field is equally important. Social change could be achieved through training that offers
continuing education credits or units in a way that influences change in the design and
implementation of service pathways and in the inclusion of PWD in all aspects of
community living that increases community inclusion. Doing so may build capacity to
serve women with disabilities while supporting them and their families or caregivers in
maneuvering all the reproductive cancer issues raised within this current study. Training
in the form of technical assistance could also help in reducing disparities of health as
described below.
An example of a positive social change can be showcased in the work done by the
Ohio Disability and Health Program (ODHP) and the Ohio Department of Health’s
Creating Healthy Communities (CHC) program. The CHC awarded disability-focused
technical assistance to 23 community-based awardees in Ohio. This technical assistance
included phone calls, in-person presentations, email assistance as well as virtual
conferencing. To examine the impact of these efforts on disability inclusion, CHC found
that its technical assistance led to a prioritizing of persons with disabilities in capacity
building, including healthy eating, active living, and community wellness activities.
(Ellsworth, Smith, Havercamp, Shetterly & Robinson, 2020). This example can be
duplicated in locally relevant ways in KY to increase positive social change.
There is an identifiable need to establish a surveillance system to monitor the
health of PWD that can also stratify according to disability type, including IDD.
Hospitals and outpatient services in KY could choose to include ICD-10-CM codes that
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identify the characteristics of women with disabilities in their data collection of each
patient. Positive social change can be achieved by identifying surveillance systems
already in use in KY and determining how best to include disability-focused assistance to
all the parties involved to increase prioritizing of PWD and the use of the ICD-10CM
codes. As part of their quality outcomes efforts, hospital systems and outpatient services
can incorporate disability-focused technical assistance to the workforce responsible for
data entry, and other appropriate personnel, with the goal of capturing PWD in data.
Leveraging hospitals and other data capturing partners to create visibility in data is a
positive social change that is feasible.
Perhaps health care providers committing to the CDC guideline of using six
questions to identify people with disabilities would be part of an effort as detailed above
to move the needle of ICD-10-CM code use that would lead to more visible persons with
disability in the data (CDC, 2020d). These six questions, as noted by CDC, address areas
of: hearing; vision; cognition; mobility; daily activities, such as bathing and dressing;
and, independent living, such as visiting a doctor or running errands in the community.
Adding these ICD-10-CM in addition to the CDC recommended questions to hospital and
health center inpatient records would help to identify and drill deeper into the
complexities of social determinants that lead to differences between women with and
without disabilities in future reproductive cancer outcomes. Several studies agree to a
need for change in creating a surveillance system that allows for improved services and
supports and, by extension, health for this population, increased collaboration between
government agencies to make PWD visible in data, as well as operational standards for
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definitions of disability (Krahn & Havercamp, 2019; Reichard et al., 2019; Wilkinson et
al., 2014). Positive social change can come by inviting inpatient hospital and outpatient
center representatives into a collaborative discussion on how to include 1CD-10-CD
codes that identify women with IDD without requiring the hospitals to do much more that
they are already doing.
When women attend medical appointments or screening services, it is likely that
certain barriers present difficulties that prevent them from receiving quality services.
Consistent care and frequency of primary care has not been shown to improve BCC
screening rates for women with disabilities, revealing the need to explore system-level
factors (Plourde et al., 2018). Some of these factors include health literacy/lack of
information/knowledge of risk factors, personal reasons, environmental factors, cost,
transportation, health care access, attitude and knowledge of healthcare providers and
referral patterns, prior negative health care experiences, as well as psychosocial factors
(Akinlotan et al., 2017; Magasi, et al., 2019a &b; Merten et al., 2015; Reis, et al., 2015;
Todd & Stuifbergen, 2012; Yankaskas, et al., 2010). These studies advocate for social
change that addresses the environmental and physical barriers that prevent quality
services for this target population because the best way to reduce cancer rates is through
prevention and early detection. That women with disabilities and reproductive cancers
were hospitalized at an older age than women without disabilities points to gaps in
continuous regular screening and prevention services at an earlier age for women with
disabilities long before any problems occur. Building capacity for environmental designs
that allow access to facilities—as well as access to the actual services—is an important
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social change toward health equity for cancer outcomes for women with disabilities. CC
was the highest type of cancer from the IHD data noted in this study, and although this is
a statewide concern, CC screening for women with disabilities would present many more
physical barriers, and strategies to meet these and other challenges should be explored.
This is an area that positive social change can be magnified by adopting a leveraging of
partners conducting screening services and offering technical assistance towards
prioritization of accessible screening services for women with disabilities, that include
women with IDD.
I want to acknowledge the CC screening occurring in KY as noted from 2016 and
2018 BFRSS data in chapter 2 of this current study. There was a slight increase of CC
screening for those ages 21-35, but a decrease for those aged 35-50 and 51-65 years old.
Given the current study’s results indicated the highest number of women with disabilities
receiving inpatient hospitalization services were aged 55-59 years old and 50-54 years
old for OSD, does call for reaching women for prevention and continuous regular
screening at younger ages.
As noted from the 2018 BRFSS data, 75.5 % is the prevalence for CC screening
rate for women with disabilities, lagging the 85.8% CC screening prevalence for women
without disabilities. In addition, women with mobility and vision disabilities had
decreased CC screening lagging other types of disabilities. This is an area that would
benefit from positive social change, by focusing strategies and resources in KY, to make
CC screening accessible for those with mobility and vision disabilities and perhaps
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reducing the disease. This calls for environments and infrastructure change that is
inclusive in the health services provider community.
The CDC, through a collaboration of local agencies, partnerships, and
cooperatives, offers low-cost or free breast and CC screenings for eligible women (CDC,
2020g). In KY, this work is carried out by the Kentucky Women's Cancer Screening
Program (KWCSP) (KCHFS, 2017b). KWCSP has, at the mention of this study,
partnered with the Kentucky Inclusive Health Collaborative at the Human Development
Institute at the University of Kentucky to identify the barriers from a lived experience
that women with disabilities face during access to BCC screening (Wellness4ky.gov,
2020). This partnership worked on an assessment to identify the barriers in KY for
targeted strategies that would hopefully removing barriers, hence increasing BCC
screening in KY. This work has already started and is such a great positive change and a
direct impact influenced by this current study. Given that a majority of the women in this
study were found to be utilizing public funding, it is possible that many more women in
KY can benefit from increased BCC screening through the KWCSP services. The
KWCSP partners with healthcare providers across the state, and collaboration with these
providers to ensure barriers are removed for all women in a way that both women with or
without disabilities receive USPSTF-recommended screenings may greatly reduce the
regional and age disparities noted in this study.
Conclusion
This research was an observational, quantitative, and cross-sectional study whose
target population was women with and without disabilities diagnosed with a reproductive
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cancer in the state of KY between the years of 2015 to 2018. IHD and OSD data from the
KCHFS was analyzed using the descriptive information provided in the data sets. The
two data sets affirmed that geographic location of residence was associated with a
discharge from treatment with a diagnosis of a reproductive cancer. Surprisingly, there
was a distribution of reproductive cancers to the higher median income regions/counties.
The IHD data found the insurance payer type significant while OSD data found age and
county of residence to be a significant contributor to discharge for concerns related to a
reproductive cancer. Public health insurance was more likely the most frequently utilized
type of insurance, and women with disabilities had longer hospital stays. CC was found
to be the leading type of reproductive cancer in both data sets. More research that
explores the differences in CC diagnoses between women with and without disabilities is
needed as is research that examines the accessibility of BCC screening services in KY for
women with disabilities.
I was able to confirm several earlier studies as well as add to the SDOH
framework that health factors contribute to CC as well as other reproductive cancers. The
highest rates of cancer were associated with higher income regions, calling into question
secondary prevention measures within these regions and whether services in KY are
concentrated more so in rural versus urban areas. The study also noted the significant
association with public insurance and with nearly $48,000 a minute reimbursed to
providers in rural counties (Anthes, 2018), the integrity of public insurance is at stake,
and value-based reforms to increase the share of women in KY who access BCC
screening based on USPSTF’s most current guidelines is a responsibility that cannot be
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taken lightly. The idea that women with disabilities were older in the IHD data and
younger in the OSD data reveals complexities of whether women with disabilities were
receiving care of screening, diagnosis, and treatment when they needed it. It is most
encouraging to note that positive social change, a direct impact of this current study, is
already occurring. The next best step would be to advocate for accessible BCC screening
through inclusive environmental designs for all types of disabilities to close the gap
between the differences noted for women with and without disabilities to ensure health
equity for all women in KY.
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Appendix A: Patient Status
The patient status variable is information available from the Kentucky Cabinet for Health
and Family Services (KCHFS) inpatient database identifies more than 40 discharge or
transfer scenarios following a course of inpatient or outpatient reproductive cancer care.
These variables will help to identify women with an IDD not otherwise noted in the
diagnosis and provide yet another way in which to validate the data. The KCHFS
discharge or transfer variables are as follows:
•

Unknown Status

•

Routine discharge (home/self-care)

•

Inpatient-other short-term hospital

•

Skilled nursing facility (SNF)

•

Intermediate care facility (ICF)

•

Designated Cancer Center or Children's Hospital

•

Home health

•

Left/discontinued care AMA

•

Admitted as inpatient to this hospital (Medicare only)

•

Expired/Did not recover

•

Discharged/transferred to court/law enforcement

•

Still Patient

•

Expired at home (Medicare, CHAMPUS claims only)

•

Expired in a medical facility (Medicare, CHAMPUS claims only for hospice care)

•

Expired-place unknown (Medicare, CHAMPUS claims only for hospice care)
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•

Discharged/transferred to a federal hospital

•

Hospice-home

•

Hospice-medical facility

•

Transfer w/in institution to Medicare swing bed

•

Discharged/transferred to rehab facility or hospital unit

•

Discharged/transferred to long-term care hospital

•

Discharged/transferred to nursing facility certified under Medicaid -not Medicare

•

Discharged/transferred to psychiatric hospital or psychiatric distinct part unit of a

hospital
•

Discharged/transferred to critical access hospital (CAH)

•

Discharged/transferred to a designated disaster alternate care

•

Discharged/transferred to another type of healthcare institution not otherwise

defined
•

Discharged/transferred to another institution for outpatient services as specified in
the plan

•

of care

Discharged/transferred to another institution for outpatient services as specified in
the plan of care

•

Discharged to Home or Self Care with a Planned Acute Care Hospital Inpatient
Readmission

•

Discharged/Transferred to a Short-Term General Hospital for Inpatient Care with
a Planned Acute Care Hospital Inpatient Readmission
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•

Discharged/Transferred to a SNF with Medicare Certification with a Planned
Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to a that provides Custodial or Supportive Care with a
Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to a Designated Cancer Center or Children's Hospital
with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to Home Under Care of Organized Home Health
Organization with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to Court/Law Enforcement with a Planned Acute Care
Hospital Inpatient Readmission

•

Discharged/Transferred to a Federal Healthcare Facility with a Planned Acute
Care Hospital Inpatient Readmission

•

Discharged/Transferred to a Hospital-based Medicare Approved Swing Bed with
a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to an IFR including Rehabilitation Distinct Part of a
Hospital with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to a Medicare Certified Long Term Care Hospital
(LTCH) with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to a Nursing Facility Certified by Medicaid but not
Certified by Medicare with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to a Psychiatric Hospital or Psychiatric Distinct Part of a
Hospital with a Planned Acute Care Hospital Inpatient Readmission
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•

Discharged/Transferred to a Critical Access Hospital (CAH) for Inpatient Care
with a Planned Acute Care Hospital Inpatient Readmission

•

Discharged/Transferred to another type of Health Care Institution not Defined in
this Code List with a Planned Acute Care Hospital Inpatient Readmission
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Regional Map of Kentucky Showing Median Household Incomes
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Appendix C
Kentucky Counties by Federal Information Processing Standard Code and Health Factor Rank
County FIPS names

FIPS
21001
21003
21005
21007
21009
21011
21013
21015
21017
21019
21021
21023
21025
21027
21029
21031
21033
21035
21037

Name
Adair
Allen
Anderson
Ballard
Barren
Bath
Bell
Boone
Bourbon
Boyd
Boyle
Bracken
Breathitt
Breckinridge
Bullitt
Butler
Caldwell
Calloway
Campbell

Health
Factor Rank
72
68
12
70
43
102
111
2
28
44
7
45
117
52
21
73
31
23
4

21039
21041
21043
21045
21047
21049
21051
21053
21055
21057
21059
21061
21063
21065
21067
21069
21071
21073
21075
21077
21079

Carlisle
Carroll
Carter
Casey
Christian
Clark
Clay
Clinton
Crittenden
Cumberland
Daviess
Edmonson
Elliott
Estill
Fayette
Fleming
Floyd
Franklin
Fulton
Gallatin
Garrard

40
78
98
100
61
15
120
93
88
84
9
63
108
99
10
62
103
25
104
67
48
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21081
21083
21085
21087
21089
21091
21093
21095
21097
21099
21101
21103
21105
21107
21109
21111
21113
21115
21117
21119
21121
21123
21125
21127
21129
21131
21133
21135

Grant
Graves
Grayson
Green
Greenup
Hancock
Hardin
Harlan
Harrison
Hart
Henderson
Henry
Hickman
Hopkins
Jackson
Jefferson
Jessamine
Johnson
Kenton
Knott
Knox
Larue
Laurel
Lawrence
Lee
Leslie
Letcher
Lewis

64
74
92
49
37
8
22
110
34
59
30
27
56
42
109
47
20
75
24
106
112
33
79
90
115
113
101
107

21137
21139
21141
21143
21145
21147
21149
21151
21153
21155
21157
21159
21161
21163
21165
21167
21169
21171
21173
21175
21177
21179
21181
21183
21185
21187
21189
21191

Lincoln
Livingston
Logan
Lyon
McCracken
McCreary
McLean
Madison
Magoffin
Marion
Marshall
Martin
Mason
Meade
Menifee
Mercer
Metcalfe
Monroe
Montgomery
Morgan
Muhlenberg
Nelson
Nicholas
Ohio
Oldham
Owen
Owsley
Pendleton

85
65
58
16
29
116
38
13
114
55
18
105
54
36
95
26
66
81
41
96
80
11
83
76
1
60
119
46

156
21193
21195
21197
21199
21201
21203
21205
21207
21209
21211
21213
21215

Perry
Pike
Powell
Pulaski
Robertson
Rockcastle
Rowan
Russell
Scott
Shelby
Simpson
Spencer

91
89
94
77
53
69
51
82
5
14
35
6

21217
21219
21221
21223
21225
21227
21229
21231
21233
21235
21237
21239

Taylor
Todd
Trigg
Trimble
Union
Warren
Washington
Wayne
Webster
Whitley
Wolfe
Woodford

39
57
32
50
86
17
19
97
87
71
118
3

Note. The Federal Information Processing Standard (FIPS) code is a unique identifier given to all U.S. counties as assigned by the
American National Standards Institute. The first two digits (i.e., 21) identify the state, Kentucky. The remaining three digits
identify the county within Kentucky.

.
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Inpatient Hospital Discharges Output
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Parameter Estimates

Diagnosis_ReprCancer
Cancer of the Uterus

a

Intercept
FIbhealthfactor
[Dischargestatus=0]
[Dischargestatus=1]
[AGE_GROUP=6]
[AGE_GROUP=7]
[AGE_GROUP=8]
[AGE_GROUP=9]
[AGE_GROUP=10]

B
41.094

Wal
Std. Error
d
2575.447 .000

df
1

.078

.105 .551

1

.458

-11.281

1066.831 .000

1

.992

.
8417.542
5255.267
5464.627
4048.186

.
.000
.000
.000
.000

0
1
1
1
1

.
1.000
1.000
1.000
1.000

2191.841 .000

1

.994

3642.569
3621.899
3600.416
3803.491
.338

.000
.000
.000
.000
.306

1
1
1
1
1

1.000
1.000
1.000
1.000
.580

1.647E7
1.021
1.433
.939
1.339
1.206

.
.
1078.209 .000

0
1

.
1.000

.
1.156

0c
.007
.143
.220
.599
-15.619

[AGE_GROUP=11]
[AGE_GROUP=12]
[AGE_GROUP=13]
[AGE_GROUP=14]
[AGE_GROUP=15]

.020
.360
-.063
.292
.187

[AGE_GROUP=16]
[MSSOP=1]

0c
.145

Sig. Exp(B)
.987
1.081
1.261E5
.
1.007
1.154
1.246
1.821

95% Confidence Interval
for Exp(B)
Upper
Lower Bound
Bound
.880

1.329

.000

.b

.
.000
.000
.000
.000

.
.b
.b
.b
.b

.000

.b

.000
.000
.000
.000
.621

.b
.b
.b
.b
2.340

.
.000

.
.

b
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[MSSOP=2]

Cancer of Breast

[MSSOP=3]
[MSSOP=4]
[MSSOP=5]
Intercept
FIbhealthfactor
[Dischargestatus=0]
[Dischargestatus=1]
[AGE_GROUP=6]
[AGE_GROUP=7]
[AGE_GROUP=8]
[AGE_GROUP=9]
[AGE_GROUP=10]
[AGE_GROUP=11]
[AGE_GROUP=12]
[AGE_GROUP=13]
[AGE_GROUP=14]
[AGE_GROUP=15]
[AGE_GROUP=16]
[MSSOP=1]

-13.580
-.116
-.603
0c
40.534
.078
-11.402
0c
.344
-.084
.208
.272
-15.536
.086
.580
.156
.270
.218
0c
.011

831.056 .000
.584
3607.679
.
2575.447
.105

1

.039
.000
.
.000
.547

1
1
0
1
1

1066.831 .000

1

.
8417.542
5255.267
5464.627
4048.186

.
.000
.000
.000
.000

0
1
1
1
1

2191.841 .000

1

3642.569
3621.899
3600.416
3803.491
.360
.
1078.209

1
1
1
1
1
0
1

.000
.000
.000
.000
.368
.
.000

1.266E6
.843
.891
1.000
.547
.
.
.987
.460
1.081
1.117E.991
5
.
.
1.000
1.410
1.000
.919
1.000
1.231
1.000
1.312
1.789E.994
7
1.000
1.090
1.000
1.785
1.000
1.168
1.000
1.309
.544
1.244
.
.
1.000
1.011
.987

.000

.b

.284
.000
.

2.797
.b
.

.880

1.328

.000

.b

.
.000
.000
.000
.000

.
.
.b
.b
.b

.000

.b

.000
.000
.000
.000
.614
.
.000

.b
.b
.b
.b
2.520
.
b
.

b
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[MSSOP=2]
[MSSOP=3]

Cancer of Cervix

[MSSOP=4]
[MSSOP=5]
Intercept
FIbhealthfactor
[Dischargestatus=0]
[Dischargestatus=1]
[AGE_GROUP=6]
[AGE_GROUP=7]
[AGE_GROUP=8]
[AGE_GROUP=9]
[AGE_GROUP=10]
[AGE_GROUP=11]
[AGE_GROUP=12]
[AGE_GROUP=13]
[AGE_GROUP=14]
[AGE_GROUP=15]
[AGE_GROUP=16]
[MSSOP=1]

-12.779

1

.988

2.820E6

.000

.b

1

.278

2.036

.564

7.353

1
0
1
1

1.000
.
.987
.445

1.025
.

.000
.

.b
.

.882

1.332

1066.831 .000

1

.992

.000

.b

.
8417.542
5255.267
5464.627
4048.186

.
.000
.000
.000
.000

0
1
1
1
1

.
1.000
1.000
1.000
1.000

2191.841 .000

1

.994

3642.569
3621.899
3600.416
3803.491
.318
.
1078.209

1
1
1
1
1
0
1

1.000
1.000
1.000
1.000
.343
.
1.000

1.084
1.306E5
.
1.070
.967
1.016
1.421
1.820E7
1.065
1.552
1.112
1.102
1.352
.
1.630

831.056 .000

.711

.655

.025
0c
40.497
.080

3607.679
.
2575.447
.105

-11.246
0c
.067
-.034
.016
.351
-15.519
.063
.439
.106
.097
.302
0c
.489

1.17
8
.000
.
.000
.582

.000
.000
.000
.000
.899
.
.000

.
.000
.000
.000
.000

.
.
.b
.b
.b

.000

.b

.000
.000
.000
.000
.725
.
.000

.b
.b
.b
.b
2.523
.
b
.

b
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[MSSOP=2]
[MSSOP=3]

Cancer of Ovary

[MSSOP=4]
[MSSOP=5]
Intercept
FIbhealthfactor
[Dischargestatus=0]
[Dischargestatus=1]
[AGE_GROUP=6]
[AGE_GROUP=7]
[AGE_GROUP=8]
[AGE_GROUP=9]
[AGE_GROUP=10]
[AGE_GROUP=11]
[AGE_GROUP=12]
[AGE_GROUP=13]
[AGE_GROUP=14]
[AGE_GROUP=15]

1

.989

9.593E6

.000

.b

1

.091

2.874

.844

9.785

1
0
1
1

1.000
.
.993
.468

3.835
.

.000
.

.b
.

.878

1.327

1

.991

.000

.b

.

0

.

.

.

-14.922

8612.820 .000

1

.999

.000

.b

-1.736
-.916
-1.273

5255.267 .000
5464.627 .000
4048.186 .000

1
1
1

1.000
1.000
1.000

.000
.000
.000

.b
.b
.b

-15.867

2191.841 .000

1

.994

.000

.b

3642.569
3621.899
3600.416
3803.491

1
1
1
1

1.000
1.000
1.000
1.000

1.079
8.795E6
.
3.308E7
.176
.400
.280
1.285E7
.711
1.091
.694
.632

.000
.000
.000
.000

.b
.b
.b
.b

1

.310

.559

.182

1.718

-11.554

831.056 .000

1.056

.625

1.344
0c
24.950
.076

3607.679
.
3045.855
.105

-11.641
0c

-.340
.087
-.365
-.458
-.582

2.85
2
.000
.
.000
.527

1066.831 .000
.

.000
.000
.000
.000
1.03
.573
1
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[AGE_GROUP=16]
[MSSOP=1]
[MSSOP=2]
[MSSOP=3]

Cancer of Other Female
Genitals

[MSSOP=4]
[MSSOP=5]
Intercept
FIbhealthfactor
[Dischargestatus=0]
[Dischargestatus=1]
[AGE_GROUP=6]
[AGE_GROUP=7]
[AGE_GROUP=8]
[AGE_GROUP=9]
[AGE_GROUP=10]
[AGE_GROUP=11]
[AGE_GROUP=12]
[AGE_GROUP=13]
[AGE_GROUP=14]
[AGE_GROUP=15]

0c

.

0

.

15.105

1951.113 .000

1

.994

1.824

1826.188 .000

1

.999

15.109

1626.133 .000

1

.993

.498
0c
40.069
.086

4134.356 .000
.
.
2575.447 .000
.105 .663

1
0
1
1

1.000
.
.988
.416

-11.227

1066.831 .000

1

.992

.
8417.542
5255.267
5464.627
4048.186

.
.000
.000
.000
.000

0
1
1
1
1

.
1.000
1.000
1.000
1.000

2191.841 .000

1

.994

3642.569
3621.899
3600.416
3803.491
.000

1
1
1
1
1

1.000
1.000
1.000
1.000
.

0c
.198
-.102
-.035
.165
-15.798
.126
.296
-.063
.286
.040

.

.000
.000
.000
.000
.

.
3632634
.090
6.196
3643938
.360
1.646
.
1.089
1.331E5
.
1.219
.903
.966
1.179
1.378E7
1.135
1.345
.939
1.331
1.041

.

.

.000

.b

.000

.b

.000

.b

.000
.

.b
.

.886

1.339

.000

.b

.
.000
.000
.000
.000

.
.
.b
.b
.b

.000

.b

.000
.000
.000
.000
1.041

.b
.b
.b
.b
1.041

b
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[AGE_GROUP=16]
[MSSOP=1]
[MSSOP=2]

0c
.212

.
.
1078.209 .000

0
1

.
1.000

-14.190

831.056 .000

1

.986

.
1.236
6.873E7
1.104
.862
.

[MSSOP=3]
.099
.000
.
1
.
[MSSOP=4]
-.148
3607.679 .000
1 1.000
c
[MSSOP=5]
0
.
.
0
.
a. The reference category is: 8.
b. Floating point overflow occurred while computing this statistic. Its value is therefore set to system missing.
c. This parameter is set to zero because it is redundant.

.
.000

.
.

.000

.b

1.104
.000
.

1.104
.b
.

b
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Parameter Estimates

a

DiagofReproCancer
Cancer of Uterus
Intercept

Cancer of Breast

Std.
B
Error
27.435 1034.810

HealthFactors
[Dischstatusofwoman=0]
[Dischstatusofwoman=1]
[age_group=6]
[age_group=7]
[age_group=8]
[age_group=9]
[age_group=10]

.027
-8.488
0b
-.106
-.651
-1.057
-.872
-14.850

[age_group=11]
[age_group=12]
[age_group=13]
[age_group=14]
[age_group=15]
[age_group=16]
Intercept
HealthFactors
[Dischstatusofwoman=0]

-.411
-.391
-.146
-.108
-.041
0b
29.200
.026
-8.802

Wald
.001

1

Sig.
.979

.046
.346
.314 729.377
.
.
2472.474
.000
1803.366
.000
1679.515
.000
1562.281
.000
1034.810
.000

1
1
0
1
1
1
1
1

.556
.000
.
1.000
1.000
.999
1.000
.989

1.027
.000
.
.900
.521
.348
.418
3.554E-7

.939
.000
.
.000
.000
.000
.000
.000

1.124
.000
.
.c
.c
.c
.c
.c

1387.691
1350.745
1318.307
1312.907
1346.966
.
1034.810
.046

1
1
1
1
1
0
1
1

1.000
1.000
1.000
1.000
1.000
.
.977
.578

.663
.676
.864
.897
.960
.

.000
.000
.000
.000
.000
.

.c
.c
.c
.c
.c
.

1.026

.937

1.123

1

.000

.000

9.076E-5

.000

.000
.000
.000
.000
.000
.
.001
.310
1167.22
.258
5

df

Exp(B)

95% Confidence
Interval for Exp(B)
Lower
Upper
Bound
Bound
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Cancer of Cervix

[Dischstatusofwoman=1]
[age_group=6]
[age_group=7]
[age_group=8]
[age_group=9]
[age_group=10]
[age_group=11]
[age_group=12]
[age_group=13]
[age_group=14]
[age_group=15]
[age_group=16]
Intercept
HealthFactors
[Dischstatusofwoman=0]
[Dischstatusofwoman=1]
[age_group=6]
[age_group=7]
[age_group=8]
[age_group=9]
[age_group=10]
[age_group=11]
[age_group=12]
[age_group=13]

0b
-.057
.192
-.024
-.148
-13.867
-.137
-.146
.007
-.097
.071
0b
26.626
.035
-8.288
0b
.542
.912
1.109
1.155
-12.764
1.332
.960
.644

.
.
2472.474
.000
1803.366
.000
1679.515
.000
1562.281
.000
1034.810
.000
1387.691
.000
1350.745
.000
1318.307
.000
1312.907
.000
1346.966
.000
.
.
1034.810
.001
.046
.587
.286 837.994
.
.
2472.474
.000
1803.366
.000
1679.515
.000
1562.281
.000
1034.810
.000
1387.691
.000
1350.745
.000
1318.307
.000

0
1
1
1
1
1
1
1
1
1
1
0
1
1
1
0
1
1
1
1
1
1
1
1

.
1.000
1.000
1.000
1.000
.989
1.000
1.000
1.000
1.000
1.000
.
.979
.444
.000
.
1.000
1.000
.999
.999
.990
.999
.999
1.000

.
.945
1.211
.977
.862
9.503E-7
.872
.864
1.007
.908
1.074
.

.
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.

.
.
.c
.c
.c
.c
.c
.c
.c
.c
.c
.

1.036
.000
.
1.720
2.489
3.033
3.176
2.861E-6
3.787
2.612
1.904

.947
.000
.
.000
.000
.000
.000
.000
.000
.000
.000

1.134
.000
.
c
.
.c
.c
.c
.c
.c
.c
.c

c
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Cancer of Ovary

Cancer of Other
Female Genitals

[age_group=14]
[age_group=15]
[age_group=16]
Intercept
HealthFactors
[Dischstatusofwoman=0]
[Dischstatusofwoman=1]
[age_group=6]
[age_group=7]
[age_group=8]
[age_group=9]
[age_group=10]
[age_group=11]
[age_group=12]
[age_group=13]
[age_group=14]
[age_group=15]
[age_group=16]
Intercept
HealthFactors
[Dischstatusofwoman=0]
[Dischstatusofwoman=1]
[age_group=6]
[age_group=7]

.503
.285
0b
25.160
.035
-8.475
0b
-.202
-.633
-1.136
-1.746
-14.484
-.545
-.964
-.946
-.726
-.130
0b
27.254
.032
-8.460
0b
-.867
-1.561

1312.907
.000
1346.966
.000
.
.
1034.811
.001
.046
.595
.629 181.345
.
.
2472.474
.000
1803.366
.000
1679.515
.000
1562.281
.000
1034.810
.000
1387.691
.000
1350.745
.000
1318.307
.000
1312.907
.000
1346.966
.000
.
.
1034.810
.001
.046
.493
.000
.
.
.
2472.474
.000
1803.366
.000

1
1
0
1
1
1
0
1
1
1
1
1
1
1
1
1
1
0
1
1
1
0
1
1

1.000
1.000
.
.981
.441
.000
.
1.000
1.000
.999
.999
.989
1.000
.999
.999
1.000
1.000
.
.979
.483
.
.
1.000
.999

1.654
1.330
.

.000
.000
.

.c
.c
.

1.036
.000
.
.817
.531
.321
.174
5.127E-7
.580
.381
.388
.484
.878
.

.947
6.078E-5
.
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.

1.134
.001
.
c
.
.c
.c
.c
.c
.c
.c
.c
.c
.c
.

1.033
.000
.
.420
.210

.944
.000
.
.000
.000

1.130
.000
.
c
.
.c
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[age_group=8]
-1.709 1679.515
.000
1
.999
[age_group=9]
-2.324 1562.281
.000
1
.999
[age_group=10]
-16.102 1034.810
.000
1
.988
[age_group=11]
-1.515 1387.691
.000
1
.999
[age_group=12]
-1.120 1350.745
.000
1
.999
[age_group=13]
-.790 1318.307
.000
1 1.000
[age_group=14]
-.534 1312.907
.000
1 1.000
[age_group=15]
-.209 1346.966
.000
1 1.000
b
[age_group=16]
0
.
.
0
.
a. The reference category is: 33.
b. This parameter is set to zero because it is redundant.
c. Floating point overflow occurred while computing this statistic. Its value is therefore set to system missing.

.181
.098
1.016E-7
.220
.326
.454
.586
.811
.

.000
.000
.000
.000
.000
.000
.000
.000
.

.c
.c
.c
.c
.c
.c
.c
.c
.

